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6 Abstract  
ABSTRACT 
Transposable elements, or transposons, are DNA segments that have the ability to move from one 
location on the genome to another. They have been widely utilized as molecular tools in the study 
of prokaryotes, plants, invertebrates, and recently also in vertebrates. Custom-designed 
transposons are easy to generate, as any DNA fragment can be inserted between the transposon 
ends, and this flexibility makes them suitable for a number of different purposes, such as gene 
delivery and genome modification. One of the best-characterized DNA transposition systems is 
that of the Mu bacteriophage. The simplified in vitro reaction of Mu is widely used as a tool for 
genetic studies. Mu transposition is mediated by a DNA transposition complex, the Mu 
transpososome, which is assembled when four transposase proteins bind to sequence-specific 
binding sites at each transposon end. In this thesis, two novel Mu in vitro transposition-based 
applications were established, the first for measuring the transpositional activity of transposition 
complexes, and the second for the cloning of circular DNA. In addition, hyperactive MuA 
transposase variants were generated and their properties were characterized in the context of the 
function of the Mu transpososome.  
The first part of this thesis presents a new assay for monitoring the activity of DNA 
transposition complexes. The assay is based on an in vitro transposition reaction with a special 
target plasmid, which allows positive selection of transposon insertions regardless of the nature 
of transposon used. Therefore, the assay is applicable to all types of transposons, and provides, 
for the first time, a common quality-control measure which will be essential for the evaluation 
of existing and future transposon-based applications. In this study we demonstrate the 
functionality of the assay with a set of Mu-based transposons. In addition, we show that the 
assay yields a linear response as a function of transposon DNA concentration, and also as a 
function of Escherichia coli competency. 
The second part of this thesis introduces a new method that will potentially allow any circular 
DNA, such as uncharacterized plasmids and viral genomes, to be maintained in E. coli, thereby 
simplifying functional and structural studies. This method utilizes the Mu in vitro transposition 
system to deliver both the E. coli origin of replication and a selectable marker into DNA-circles, 
which are then transformed into E. coli. This study demonstrates the utility of the assay using a 
replication-deficient plasmid, and presents altogether ten novel transposons that can be used for 
this procedure, thus enabling multiple approaches for the study of DNA-circles of interest. In 
addition, this study presents a novel means to reduce intramolecular transposition, a phenomenon 
in which a transposon inserts into itself instead of an external target DNA. Here, we show that the 
amount of intramolecular transposition is affected by the ratio of transposon to target DNA. In 
addition, we show that the use of MuB, and the simultaneous use of two transposons, one 
containing the replication origin and other the selectable marker, can reduce this phenomenon.  
Lastly, this thesis shows that it is possible to generate hyperactive variants of MuA transposase. 
Activity-enhancing substitutions were mapped on the Mu transpososome structure, which 
allowed us to identify the specific locations involved. Purified versions of the MuA variants 
improved the transposition efficiency of different Mu in vitro applications.   
The methods established in this thesis are useful additions to the transposon toolbox. In particular, 
the hyperactive MuA variants that were generated here will substantially improve the use and 
development of in vitro applications based on the Mu system, which could potentially include the 
development of gene therapy applications. Furthermore, the results with hyperactive MuA 
variants can be used for structure-function studies of other similar transposases or close relatives, 
such as HIV integrase, creating opportunities for accelerated progress in this field of research.  
7 Tiivistelmä  
TIIVISTELMÄ 
Transposonit ovat DNA-jaksoja, joilla on luontainen kyky liikkua kromosomissa paikasta toiseen ja 
niitä on löydetty kaikista eliöryhmistä, bakteereista ihmisiin. Transposoneja on helppo muokata ja 
niitä voidaan hyödyntää monipuolisesti eri tarkoituksiin, kuten geeninsiirtoon ja genomien 
muokkaukseen. Transposoneihin perustuvia työkaluja käytetään sekä bakteereilla, kasveilla, 
selkärangattomilla, että selkärankaisilla. Bakteriofagi Mu hyödyntää elinkierrossaan transpositiota. 
Mu:n transpositiomekanismia on tutkittu paljon, ja koeputkessa tapahtuvaa yksinkertaistettua Mu:n 
transpositioreaktiota käytetään laajasti geeniteknologian työkaluna. Yksinkertaistetussa reaktiossa 
Mu:n transpositiokompleksi koostuu Mu-DNA:sta, jonka päihin on sitoutuneena neljä MuA-
proteiinia. Väitöskirjatyöni tavoitteena oli kahden erilaisen Mu:n transpositioreaktioon perustuvan 
menetelmän kehittäminen. Ensimmäinen menetelmä oli tarkoitettu transpositiokompleksien 
tehokkuuden mittaamiseen ja toinen DNA-renkaiden monistamiseen Escherichia coli -soluissa 
transposonien avulla. Lisäksi työssäni tutkittiin Mu:n transpositioreaktion tehokkuuden parantamista 
muokkaamalla transpositionreaktiossa tarvittavasta MuA proteiinista eri versioita.  
Ensimmäiseksi tässä työssä esitellään uusi menetelmä transpositiokompleksien aktiivisuuden 
mittaamiseen. Kehitetty menetelmä perustuu koeputkessa tapahtuvaan transpositioreaktioon, 
jossa hyödynnetään kohde-DNA:na erityistä plasmidia. Tämä plasmidi mahdollistaa 
transpositiotuotteiden valinnan riippumatta siitä mitä ominaisuuksia transposoni sisältää.  Täten 
kehitetty menetelmä soveltuu kaikille transposoneille ja on merkittävä parannus jo olemassa 
olevien ja kehitteillä olevien transpositioon perustuvien menetelmien arvioimiseen. Työssä 
todistetaan menetelmän toimivuus erilaisten Mu-transposonien avulla. Lisäksi työssä osoitetaan 
että menetelmä antaa vertailukelpoisia tuloksia riippumatta transposoni-DNA:n määrästä, tai 
transformaatiossa käytettävien Escherichia coli -solujen transformaatiotehokkuudesta.  
Toinen työssä esiteltävä uusi menetelmä mahdollistaa periaatteessa minkä tahansa rengasmaisen 
DNA:n, kuten vielä tuntemattoman plasmidin tai virus-DNA:n monistamisen ja säilyttämisen E. coli -
soluissa. Kehittämässämme menetelmässä hyödynnetään Mu:n koeputkessa tapahtuvaa 
transpositioreaktiota viemään DNA-renkaisiin replikaation aloituskohta ja antibioottivalinnan 
mahdollistava geeni, jonka jälkeen reaktiotuotteet viedään E. coli -soluihin. Tässä työssä osoitetaan 
menetelmän toimivuus käyttäen plasmidia, joka ei itse pysty replikoitumaan käytetyissä E. coli 
soluissa ja esitellään kymmenen uutta transposonia, jotka mahdollistavat DNA-renkaiden 
monipuolisen tutkimisen. Johtuen transposonien sisältämästä replikaation aloituskohdasta, menetelmä 
tuottaa myös jonkun verran taustapesäkkeitä, jotka eivät sisällä haluttua DNA-rengasta vaan 
aiheutuvat siitä, että transposoni on ulkopuolisen kohde DNA:n sijasta liittynyt itseensä 
(intramolekulaarinen transpositio). Tässä työssä osoitetaan että transposonin ja DNA-renkaiden 
välinen suhde vaikuttaa intramolekulaarisen transposition määrään. Lisäksi osoitetaan että käyttämällä 
MuB-proteiinia tai yhtäaikaisesti kahta transposonia (joista toinen sisältää replikaation aloituskohdan 
ja toinen antibioottivalinta geenin) voidaan vähentää intramolekulaarisen transposition määrää.  
Väitöskirjatyössä osoitetaan lisäksi, että MuA transposaasista voidaan kehittää hyperaktiivisia 
muotoja. Työssä selvitetään myös transpositiotehokkuutta lisäävien muutosten sijainti suhteessa 
Mu transpositiokompleksin rakenteeseen ja osoitetaan, että muokattujen MuA-proteiinien 
avulla voidaan parantaa Mu:n transpositioon perustuvien menetelmien tehokkuutta.  
Työssä kehitetyt menetelmät ovat tarpeellinen lisä transposoneja hyödyntävien menetelmien 
joukkoon. Lisäksi kehitetyt hyperaktiiviset MuA-muodot parantavat merkittävästi Mu:n 
transpositioon perustuvien menetelmien käytön tehokkuutta, mistä on hyötyä muun muassa 
geeniterapiaan liittyvien sovellusten kehityksessä. Muokattujen MuA-proteiinien avulla saatuja 
tuloksia voidaan hyödyntää myös tutkiessa muita samankaltaisia proteiineja, joihin kuuluu 
myös muun muassa HI-viruksen integraasi.   
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ABBREVIATIONS 
aa amino acid 
Ap ampicillin 
ATP adenosine triphosphate 
BAF  barrier-to-autointegration factor 
bp base pair(s) 
BSA bovine serum albumin 
CDC  cleaved donor complex 
cDNA complementary deoxyribonucleic acid 
Cm chloramphenicol 
C-terminal carboxy-terminal 
CRISPR Clustered regularly-interspaced short palindromic repeats 
DD(E/D) domain which contain a triad of highly conserved amino acids 
[aspartate (D), aspartate, and glutamate (E), or third aspartate] 
DMSO  dimethylsulfoxide 
DNA deoxyribonucleic acid 
DSB double stranded break 
ep error prone 
ERV  endogenous retrovirus  
HIV human immunodeficiency virus 
HPLC high-pressure liquid chromatography 
HTH heliz-turn-helix 
HUH-transposase  tyrosine-histidine-hydrophobic-histidine transposase 
IAS internal activating sequence 
ICE  integrative and conjugative element  
IHF E.coli integration host factor 
IPTG isopropyl-β-D-1-thiogalactopyranoside 
IS insertion sequence 
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LE left end 
LER left end-enhancer-right end; synaptic complex in Mu transposition 
LINE long interspersed repeated element 
LTR long terminal repeat 
MITE miniature inverted-repeat transposable element 
MoMLV Moloney Murine Leukemia Virus  
MuA bacteriophage Mu transposase protein A 
MuB bacteriophage Mu transposase protein B 
NMR nuclear magnetic resonance  
N-terminal amino-terminal 
OH hydroxide 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PEG polyethylene glycol 
PLE Penelope-like element 
RE right end 
RNA ribonucleic acid 
RNaseH ribonuclease H 
SDS sodium dodecyl sulphate 
SINE short interspersed repeated element 
SNP single-nucleotide polymorphism 
SSC stable synaptic complex 
TE transposable element 
TIR terminal inverted repeat 
TriNex trinucleotide change 
YR –element tyrosine recombinase encoding element  
V(D)J variable (diversity) joining; antigen receptor gene segments 
wt wild type 
X-gal 5-bromo-4-chloro-3-inodyl-β-D-galactopyranoside 
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1 INTRODUCTION 
 Transposable elements are major components of genomes 
Transposable elements (TEs), or transposons, are defined segments of DNA that have 
the ability to move or copy themselves into another location within and between 
genomes, even if those locations are non-homologous (reviewed by Craig et al. 2002; 
Craig et al. 2015). Transposons were first identified in the 1940s by Barbara 
McClintock through experimentation with maize (reviewed by McClintock 1987). She 
proposed that genomes were dynamic and subject to rearrangements and alterations. 
These radical suggestions were met with skepticism and transposons were long thought 
of as useless or junk DNA. Since then, however, knowledge of transposons has vastly 
increased and, far from being considered junk DNA, they are now viewed as major 
components of genomes which play an important role in evolution, particularly by 
controlling gene activity (reviewed by Biemont and Vieira 2006).  
A variety of TEs have been found in all three domains of life (Aziz et al. 2010; 
Feschotte and Pritham 2007; Filee et al. 2007; Siguier et al. 2014), and the number of 
identified elements is continuously growing due to the advent of high-throughput 
genome sequencing. TEs can make up a large proportion of a genome, for instance, 
45% of the human genome (Lander et al. 2001), 85% of the maize genome (Schnable 
et al. 2009) and 37.5% of the mouse genome (Waterston et al. 2002). TEs tend to be 
more abundant in larger versus smaller genomes; however, no straightforward 
relationship between genome size and TE diversity (number of TE types) has been 
found (reviewed by Elliott and Gregory 2015). 
Transposons can influence the evolution of their host by altering gene function; this 
can occur through insertion, by inducing chromosomal rearrangements, and by 
providing novel genetic material (reviewed by Feschotte and Pritham 2007; Rebollo et 
al. 2012). A prime example of beneficial transposon-derived sequences that have been 
co-opted by the host is found in the RAG genes, which are involved in immunoglobulin 
V(D)J joining (reviewed by Fugmann 2010; Gellert 2002). Most transposon insertions 
in genomes are molecular fossils that have been inactivated by rearrangements or 
mutations, and are incapable of further transposition. However, some transposons are 
actively mobile and cause new insertions. New insertions are most often benign, 
extremely rarely beneficial, and occasionally harmful, with the potential to cause 
various diseases, particularly cancers (Lee et al. 2012; reviewed by Goodier and 
Kazazian 2008).  
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 Classification of transposable elements  
Today, knowledge regarding transposable elements, such as their transposition 
mechanisms and diversity, has increased dramatically. However, somewhat 
paradoxically, the classification of these elements has become more challenging. 
Elements have been divided into classes based on their transposition mechanisms, 
sequence similarities, and structural relationships, and these classes have been further 
be divided into various subgroups, such as subclasses, orders, superfamilies, families, 
and subfamilies (reviewed by Piegu et al. 2015; Wicker et al. 2007).  
The first TE classification system separated TEs into two main classes based on their 
transposition intermediate: RNA (class I or retrotransposons) or DNA (class II or DNA 
transposons) (reviewed by Finnegan 1989). In Wicker’s proposal, presented in Table 1, 
these two main classes are further subdivided into subclasses, orders, and superfamilies 
(reviewed by Wicker et al. 2007). Wicker’s proposal (reviewed by Wicker et al. 2007), 
and the similar Repbase proposal (reviewed by Jurka et al. 2005; Kapitonov and Jurka 
2008), have been widely used in TE studies. However, critics have identified certain 
weaknesses in these approaches, such as the fact that they focus only on eukaryotic 
elements, excluding prokaryotic transposons, and that the classification fails to reflect 
phylogeny and evolutionary relationships consistently (reviewed by Piegu et al. 2015; 
Seberg and Petersen 2009).  
Table 1. Wicker’s proposal for the classification of eukaryotic TEs (Wicker et al. 2007) 
 Order Superfamilies 
Class I (retrotransposons)   
 LTR Ty, Copia, Gypsy, Bel-Pao, Retrovirus, ERV 
 DIRS DIRS, Ngaro, VIPER 
 PLE Penelope 
 LINE R2, RTE, Jockey, L1, I 
 SINE tRNA, 7SL, 5S 
   
Class II (DNA transposons) 
–subclass I 
  
 TIR Tc1-Mariner, hAT, Mutator, Merlin, Transib, 
P, PiggyBac, PIF-Harbinger, CACTA 
 Crypton Crypton 
   
Class II (DNA transposons) 
–subclass II 
  
 Helitron Helitron 
 Maverick Maverick-Polinton 
 Retrotransposons 
Retrotransposons (class I elements) act through an RNA intermediate, moving via a 
“copy and paste” mechanism. This involves transcription of an RNA intermediate from 
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a genomic copy, reverse transcription of the RNA intermediate by an element-encoded 
reverse transcriptase enzyme, and insertion of the cDNA copy at a new genome site 
(reviewed by Curcio and Derbyshire 2003; Goodier and Kazazian 2008). 
Retrotransposons are often highly abundant in eukaryotic genomes, especially in 
mammals (reviewed by Goodier and Kazazian 2008). Class I elements can be divided 
into long-terminal-repeat (LTR) elements (for example, endogenous retrovirus (ERV) 
elements and Ty elements of Saccharomyces cerevisiae) and non-LTR 
retrotransposons (for example, long interspersed nuclear elements (LINEs), or short 
interspersed nuclear elements (SINEs) such as Alu elements and bacterial and 
organellar group II introns) (reviewed by Beauregard et al. 2008; Wicker et al. 2007). 
In addition to the traditional class I elements, there are also two novel groups of 
retrotransposons: tyrosine recombinase (YR) -encoding elements (for example, DIRS-
like elements) and Penelope-like elements (PLEs) (reviewed by Wicker et al. 2007).  
As their name suggests, LTR retrotransposons have long terminal repeats at their ends, 
and they resemble retroviruses both structurally and mechanistically, differing mainly 
in the fact that retroviruses can form infectious virions that allow them to move 
horizontally from cell to cell, while LTR retrotransposons can only move between 
different sites within the genome of a single cell (reviewed by Beauregard et al. 2008). 
Instead, non-LTR retrotransposons do not contain LTRs and integrate into the genome 
using target-primed reverse transcription, in which cleaved DNA targets are used to 
prime reverse transcription of the element’s RNA intermediate into cDNA (reviewed 
by Beauregard et al. 2008). For integration into the genome, LTR retrotransposons 
employ integrases, YR elements utilize tyrosine recombinases, and PLEs and 
autonomous non-LTR retrotransposons use endonucleases.  Non-autonomous 
elements, of which a prominent class is SINEs, require LINEs for their propagation 
(reviewed by Okada et al. 1997; Richardson et al. 2015). 
 DNA transposons 
1.2.2.1 Eukaryotic DNA transposons 
DNA transposons (Class II elements) act through either a double- or single-stranded 
DNA intermediate (reviewed by Curcio and Derbyshire 2003; Hickman and Dyda 
2015). Based on their transposition mechanism, eukaryotic DNA transposons can be 
divided into four groups: i) classic “cut-and-paste” transposons (for example, hAT, 
Tc1/mariner, P, and piggyBac elements), ii) rolling circle transposons (Helitrons), iii) 
self-replicating transposons, which use a self-encoded DNA polymerase 
(Mavericks/Polintons), and iv) tyrosine recombinase transposons (Cryptons) (reviewed 
by Feschotte and Pritham 2007; Poulter and Goodwin 2005). Both Helitrons and 
Mavericks/Polintons probably transpose through a replicative copy-and-paste process. 
Eukaryotic DNA transposons also include non-autonomous elements, such as 
miniature inverted repeats (reviewed by Fattash et al. 2013; Feschotte et al. 2002).  
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1.2.2.2 Prokaryotic DNA transposons 
Although found in all kingdoms of life, DNA transposons are particularly prevalent in 
bacteria. Examples of prokaryotic transposons and their end organization are presented 
in Figure 1. The simplest autonomous prokaryotic DNA elements are insertion 
sequences (ISs), which contain a transposase gene flanked by inverted terminal repeats 
(IRs) (reviewed by Chandler and Mahillon 2002; Siguier et al. 2014; Siguier et al. 
2015).  Composite transposons (for example, Tn5 and Tn10) contain a pair of insertion 
elements (IS50 and IS10, respectively) which flank genetic information for antibiotic 
resistance or other properties (reviewed by Haniford 2002; Haniford and Ellis 2015). 
Complex transposons (for example Tn3) are not terminated with complete IS elements 
and may encode for several gene products (reviewed by Grindley 2002; Nicolas et al. 
2015). Integrative and conjugative elements (for example, Tn916) can integrate into 
the chromosome of their host cell and eventually self-transfer to other bacteria via 
conjugation (reviewed by Wozniak and Waldor 2010). The most elaborate prokaryotic 
elements are transposing bacteriophages, such as phage Mu, which use transposition in 
their lifecycles (reviewed by Chaconas and Harshey 2002; Harshey 2014). A novel 
class of prokaryotic transposons, casposons, has been recently proposed (Krupovic et 
al. 2014). Casposons resemble eukaryotic self-synthesizing Mavericks/Polintons 
elements; their name derives from the transposase (integrase) protein that they use, 
which is related to Cas1, a protein component of the bacterial adaptive immunity 
system CRISPR-Cas.   
 
Figure 1. Examples of prokaryotic transposons. Terminal repeats are denoted by arrows. A. 
Insertions sequence IS10 has one open reading frame which encodes the transposase (Tnp). B. 
Composite transposon Tn10 has IS10 elements at both ends flanking a gene that encodes for 
tetracycline resistance. Only one copy of IS10 encodes an active transposase. C. Complex 
transposon Tn3 has three open reading frames, which encode for transposase, site-specific 
resolvase and ampicillin resistance. D. Bacteriophage Mu is both a transposon and a 
bacteriophage. It encodes for two transposition proteins, A and B. Other genes are involved in 
regulation of transposition, lysis, head and tail genes, and host range. Drawn according to 
(Braid et al. 2004; Leach 1996).  
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 Transposases 
Transposases move DNA transposons to new locations, without the need for sequence 
homology between the transposon and the target site. Transposases contain a catalytic 
domain that mediates the breakage and joining of DNA; based on the type of the 
catalytic domain present, they can be divided in four major classes: aspartate-aspartate-
glutamate (DDE) transposases, tyrosine-histidine-hydrophobic-histidine (HUH) 
transposases, tyrosine transposases, and serine transposases (reviewed by Curcio and 
Derbyshire 2003; Hickman and Dyda 2015). DDE transposases integrate a transposon 
to a new site via direct transesterification, whereas the other transposase classes use 
covalent-protein DNA intermediates. Transposases belonging to the novel Cas1 class 
use the same chemical mechanism for DNA joining as DDE transposases do, but have 
no structural homology with the latter class (Krupovic et al. 2014).  
 DDE transposases 
Although all the above-mentioned major classes of transposases can be found in all 
kingdoms of life, the largest class is that of the DDE transposases. Members of this 
group contain the DD(E/D) domain, also called the RNase H-like fold, which is the 
most common catalytic nuclease domain fold (reviewed by Hickman and Dyda 2015; 
Montano and Rice 2011). The DD(E/D) domain contains a triad of highly conserved 
amino acids [aspartate (D), aspartate, and either glutamate (E) or a third aspartate], 
which are crucial for the coordination of metal ions required for catalysis (Kulkosky et 
al. 1992; reviewed by Hickman et al. 2010). These metal ions (most likely Mg2+ in 
vivo) are crucial cofactors for two chemical reactions catalyzed by DDE transposases: 
DNA strand cleavage and strand transfer (reviewed by Hickman and Dyda 2015). In 
the first chemical step, hydrolysis of the phosphodiester backbone at the transposon 
ends generates free 3´-OH groups. In the second step, these liberated 3´-OH groups are 
joined to the target DNA in a transesterification reaction. The nucleophilic attack on 
the target DNA normally occurs at staggered positions, generally separated by 2-9 
nucleotides, with the result that short single-stranded segments of host DNA flank the 
inserted transposon (reviewed by Curcio and Derbyshire 2003). Repair of these single-
stranded gaps by the host enzymes results in target duplication, the length of which is 
characteristic for each transposon.  
 Replicative and non-replicative transposition pathways 
All DDE transposases catalyze the same chemical reactions which are needed for DNA 
strand cleavage and strand transfer. However, the detailed mechanisms of the 
transposition pathways are transposase-specific. The transposition strategy has 
traditionally been divided into two types: replicative or non-replicative (“cut and 
paste”) (reviewed by Hickman and Dyda 2015; Turlan and Chandler 2000). 
Transposition pathways of DDE transposases are presented in Figure 2.  
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1.3.2.1 Replicative pathway 
In the replicative pathway, a new copy of the transposon is generated, and as an end 
result, one transposon copy appears at the new site and one copy remains at the old 
site. The replicative pathway can be further divided into two different types, nick-
paste-copy and nick-copy-out-paste (reviewed by Curcio and Derbyshire 2003; 
Hickman and Dyda 2015) (Figure 2.). In the nick-paste-copy pathway, only the 3´-ends 
of the transposon are nicked and joined to the target, while the transposon 5´-ends 
remain attached to the donor molecule. Fusion of the cleaved 3´-ends to a target 
molecule forms a strand transfer intermediate, also called a Shapiro intermediate 
(Shapiro 1979). Replication from the 3´-OHs in the flanking target DNA generates a 
cointegrate molecule, which consists of donor and target DNA joined by two copies of 
the transposon. The cointegrate molecule can be resolved by a recombination reaction, 
either through homologous recombination between the transposon copies or by a site-
specific recombination system encoded by the element, which yields a donor and 
recipient replicon which each have a copy of the transposon. Examples of transposable 
elements that utilize the nick-paste-copy pathway are bacteriophage Mu (reviewed by 
Chaconas and Harshey 2002; Harshey 2014) and members of the Tn3 family (reviewed 
by Grindley 2002; Nicolas et al. 2015). In the nick-copy-out-paste pathway, the 
transposase asymmetrically nicks only one 3´-end of the transposon and the released 
3´-OH group joins intramolecularly to just outside of its own 5´-end, thereby 
circularizing one strand of the transposon (reviewed by Curcio and Derbyshire 2003; 
Hickman and Dyda 2015). Replication of the 3´-OH of the flanking target DNA copies 
both transposon strands, resulting in the release of the double-stranded transposon 
circle and the repair of the donor site. The transposase cleaves the transposon ends, 
generating two 3´-OH which are then used to attack the target DNA. Examples of 
elements utilizing the nick-copy-out-paste pathway are IS911 and other members of 
the IS3 family (Sekine et al. 1994; Ton-Hoang et al. 1997; reviewed by Chandler et al. 
2015). Retroviral integrases of LTR-retrotransposons are also DDE transposases, and 
they utilize a copy-out-paste pathway (reviewed by Curcio and Derbyshire 2003) (not 
shown in Figure 2.).  LTR-retrotransposons generate a copy of their genome by 
transcription, which is followed by the generation of cDNA by reverse transcription. 
Either the 3´-ends of this cDNA contain a terminal CA dinucleotide (the 3´-CA 
dinucleotide is conserved among retrotransposons and retroviruses), or the DDE 
transposase introduces nicks at each end of the proviral DNA, exposing 3´-CA 
dinucleotides that are joined to the target (Engelman et al. 1991; Vink et al. 1991).  
1.3.2.2 Non-replicative pathway 
In the non-replicative (cut-and-paste) pathway, the transposon is excised from the 
original site and integrated into the new site (reviewed by Hickman et al. 2010; 
Hickman and Dyda 2015; Turlan and Chandler 2000) (Figure 2.). As the initial 
hydrolysis reaction of DDE transposases catalyzes the cleavage of only one strand at 
the transposon ends, elements utilizing non-replicative transposition have developed a 
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variety of strategies to cleave the second strand and thereby introduce a double-strand 
break (DSB) in order to excise themselves from the donor DNA (reviewed by Hickman 
et al. 2010; Turlan and Chandler 2000). Perhaps the simplest strategy to excise the 
transposon is to introduce DSBs by two sequential strand cleavages on opposite 
strands, a strategy used, for example, by members of the Tc1/mariner family (Dawson 
and Finnegan 2003). Another strategy is found in the bacterial insertion sequences 
IS10 and IS50, which use a hairpin formation on the transposon ends for excision 
(Bhasin et al. 1999; Kennedy et al. 1998). The hairpin is formed when the cleaved 3´-
OHs at the transposon ends attack the complementary 5´-ends of the transposon. 
Before insertion into the target DNA, the hairpin is linearized by hydrolysis at the 
transposon 3´-ends. If the transposon is first nicked at the 5´-ends, the hairpin 
formation occurs at the flanking donor DNA. This type of hairpin formation is utilized, 
for example, by members of the hAT family of eukaryotic transposons (for example the 
Hermes transposon) and the V(D)J recombination RAG1/2 recombinase (Zhou et al. 
2004; reviewed by Schatz and Swanson 2011). Instead, transposon Tn7 utilizes two 
proteins to liberate itself from the donor DNA: the TnsB protein for 3´-cleavage and 
TnsA for 5´-cleavage (Sarnovsky et al. 1996; reviewed by Peters 2014). The Tn7 
transposition pathway also demonstrates the requirement for DSBs in non-replicative 
transposition: if 5´-cleavage is prevented by mutations in TnsA, Tn7 is turned into a 
replicative transposon (May and Craig 1996).  
Excision of the non-replicative element from the donor DNA, and possibly the 
insertion of the element into target DNA, generates gaps which must be repaired. For 
most transposons, these repair steps are still unclear. Among prokaryotes, repair of the 
donor site after transposon excision can be performed utilizing homologous 
recombination, provided that a second copy of the chromosome exists (Hagemann and 
Craig 1993). It was recently shown that for the non-replicative pathway of Mu, the 
gaps created following Mu insertion are repaired by the E. coli machinery for double-
strand break repair, which involve both the replication restart proteins and homologous 
recombination proteins (Jang et al. 2012).   
Among eukaryotes, the double-stranded break caused by excision from the donor site 
can be repaired by non-homologous end joining (Robert et al. 2008; Staveley et al. 
1995; reviewed by Plasterk and van Luenen 2002). However, particularly if 
transposition occurs during replication, the double-stranded break can also be repaired 
by homologous recombination with the sister chromatid (Bender et al. 1991; Engels et 
al. 1990). For both prokaryotes and eukaryotes, although the transposon per se may be 
non-replicative, repair via homologous recombination can lead to an increase in 
transposon copy number in the genome. 
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Figure 2. Transposition pathways of DDE transposases. The mechanisms that are used to 
generate a DNA substrate for strand transfer differ between the DDE transposases. A. Mu and 
Tn3-like elements utilize transposases that nick and join the 3´ends of the transposon to the 
target, which forms a strand-transfer, or Shapiro, intermediate. Replication from the 3´OHs in 
the flanking target DNA generates a cointegrate molecule. B. IS911 and other IS3-like elements 
family members utilize transposases that nick only one 3´end of the transposon and the released 
3´OH group joins intramolecularly to just outside of its own 5´end, thereby circularizing one 
strand of the transposons. Replication results to a release of double stranded transposon circle 
and repaired donor site.  Second round of transposase cleavage generates a linear transposon. C-
E. Non-replicative transposons utilize transposases that excise a double-stranded copy of the 
transposon and result in simple insertion. All DDE-transposases attack the target DNA at 
staggered positions, and when the cell repairs the resulting short single stranded segments of 
host DNA flanking the inserted transposon it generates target site duplications at both 
transposon ends. Thick black lines represent transposon DNA; thick grey lines represent 
flanking host DNA; thin black lines represent target DNA; dashed lines represent newly 
replicated DNA; circles at the ends of DNA represent exposed 3´OH groups. Drawn according 
to (Curcio and Derbyshire 2003; Hickman and Dyda 2015).  
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 Transposable bacteriophage Mu 
Mu is both a transposable element and a temperate bacteriophage of Escherichia coli 
and other Gram-negative bacteria. Mu was the first mobile element found in E. coli, 
and it has played a major role in the development of the study of mobile DNA elements 
(Taylor 1963; reviewed by Harshey 2012). Soon after its discovery, Taylor (1963) 
noted that it could induce mutations at a high rate and therefore named it Mu for 
mutator. Mu was the first TE for which an in vitro transposition reaction was 
established (Mizuuchi 1983). This has been invaluable to the study of its reaction 
chemistry and of the function of the participating proteins (reviewed by Chaconas and 
Harshey 2002; Harshey 2014). 
 Transposition mechanism of phage Mu 
Mu uses transposition at two different stages during its lifecycle (reviewed by 
Chaconas and Harshey 2002; Harshey 2014). Upon lysogenization, Mu uses non-
replicative transposition to integrate randomly into the bacterial chromosome; then, 
during the lytic stage, it uses replicative transposition to replicate its DNA. In both 
stages the transposition mechanism is the same, but the pathway for product resolution 
differs. First, the transposase protein (MuA) pairs the Mu genome ends together to 
form a transpososome. At both ends, MuA catalyzes hydrolytic nicking at the Mu-host 
junction and, during the subsequent strand-transfer reaction, the element’s freed 3´-
OHs attack the target DNA. The attack at the target DNA occurs at nearly random sites 
and at staggered positions, separated by five nucleotides. The strand-transfer reaction 
produces branched intermediates which must be resolved. During the lytic (replicative) 
stage, the intermediate is resolved by target-primed replication, leading to the 
duplication of the entire Mu genome. During the initial lysogen formation (cut-and-
paste transposition), both strands at each genome-end are cleaved, leading to a simple 
insertion without duplication. Because the target DNA is cut at staggered positions, 
single-stranded gaps are created in the host DNA which flank the inserted transposon. 
Repair of these gaps by the host results in 5-bp target site duplications, the presence of 
which is a hallmark of Mu transposition (Allet 1979; Kahmann and Kamp 1979; 
Mizuuchi 1992). 
 DNA and protein requirements in Mu transposition 
Bacteriophage Mu has a double-stranded DNA genome 36,717 base pairs in length 
(Morgan et al. 2002). The Mu DNA sites and proteins involved in Mu transposition are 
presented in Figure 3. The left (L) and right (R) ends each contain three MuA-binding 
sites (L1–L3 and R1–R3, respectively) (Craigie et al. 1984; Groenen and van de Putte 
1986; Zou et al. 1991). Three additional MuA-binding sites are also found about 1 kb 
away from the left end, in the enhancer (E) segment (also called internal activating 
sequence, or IAS). This region was originally identified as the operator sequence, and 
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hence the binding sites are named O1-O3.  Later it was found that this sequence also 
enhances transposition (Leung et al. 1989; Mizuuchi and Mizuuchi 1989; Surette et al. 
1989). The L and R ends are asymmetric and the binding sites differ in orientation and 
spacing. Between L1 and L2 exists a binding site for the E. coli protein HU, which 
bends Mu DNA to allow the assembly of transpososomes (Lavoie et al. 1996). 
Between O1 and O2 there is a binding site for the E. coli integration host factor (IHF) 
protein, which optimizes the assembly of transpososomes (Leung et al. 1989; Mizuuchi 
and Mizuuchi 1989; Surette et al. 1989). These components are sufficient for executing 
the DNA cleavage reaction in the presence of the divalent metal ion Mg2+, but the 
strand-transfer reaction additionally requires phage-encoded MuB. MuB is an ATP-
dependent protein that binds DNA non-specifically (Adzuma and Mizuuchi 1988; 
Adzuma and Mizuuchi 1989; Maxwell et al. 1987). It directs target-site selection and 
also interacts with MuA to optimize all stages of transpososome assembly (Coros et al. 
2003; Mizuno et al. 2013).  
 
Figure 3. DNA and protein requirements for Mu transposition. A. Arrangement of three MuA 
binding sites at both ends (L1-L3 and R1-R3) of the Mu genome, and also at enhancer (E) 
segment (O1-O3).   Enhancer segment is also labeled O because enhancer and operator (O) 
region overlap. Binding sites for E.coli bending protein HU and E.coli integration host factor 
(IHF) within L and E are shown. The genes regulating transposition (c, A, B) are indicated. 
Flanking DNA (FD) on both sides of the Mu genome is packaged into virions. Drawn according 
to (Akhverdyan et al. 2011; Harshey 2014). B. Domain and subdomain organization of MuA. 
The function of each subdomain is indicated. Drawn according to (Harshey 2014; Montano et 
al. 2012).  
1.4.2.1 Minimal requirements for Mu in vitro transposition 
While transpososome assembly is normally controlled by several cofactors, the 
required components can be substantially simplified using modified reaction 
conditions, particularly with the inclusion of dimethylsulfoxide (DMSO) and the 
utilization of pre-cut donor DNA (Baker and Mizuuchi 1992; Craigie and Mizuuchi 
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1986; Mizuuchi and Mizuuchi 1989; Savilahti et al. 1995). Under relaxed reaction 
conditions, transposition is possible without DNA supercoiling, the enhancer sequence, 
the MuA domain Iα (N-terminal enhancer-binding domain), HU, IHF, MuB, and the 
MuA domain IIIβ (C-terminal MuB/ClpX-binding domain) (Savilahti et al. 1995) 
(Domain organization of MuA is shown in Figure 3). In a minimal setup, the only 
requirements are a simple buffer, MuA transposase, transposon DNA in a precut linear 
form that contains only the R1 and R2 MuA binding sites at both ends, and target DNA 
(Haapa et al. 1999b; Savilahti et al. 1995). 
 Structure of MuA transposase 
MuA is a large (75 kDa, 663 amino acids) protein with a modular organization 
(Nakayama et al. 1987). It can be divided into three major domains (I, II, III) and seven 
subdomains (Iα, Iβ, Iγ, IIα, IIβ, IIIα, IIIβ) based on different structural and functional 
properties (Figure 3B). MuA domain and subdomain organization was originally 
determined by partial proteolysis (Nakayama et al. 1987). Later, structures of the 
individual subdomains (except IIIβ) were defined by nuclear magnetic resonance 
(NMR) or by X-ray crystallography (Clubb et al. 1994; Clubb et al. 1997; Montano et 
al. 2012; Rice and Mizuuchi 1995; Schumacher et al. 1997). Recently, this latter 
technique was also used to determine the structure of a Mu transpososome joined to 
target DNA that contained nearly full-length MuA, lacking only the N- and C-terminal 
domains Iα and IIIβ (Montano et al. 2012).  
The N-terminal I domain contains the Iα subdomain, which binds to the transposon 
enhancer sequence, and subdomains Iβ and Iγ, which bind to the specific MuA-binding 
sites at the transposon ends (Clubb et al. 1994; Clubb et al. 1997; Kim and Harshey 
1995; Leung et al. 1989; Schumacher et al. 1997). The central II domain contains the 
catalytic IIα subdomain and subdomain IIβ. Subdomain IIα contains a DDE residue 
triad (at positions Asp269, Asp336, and Glu392), which is crucial in the catalysis of 
strand cleavage and strand transfer (Baker and Luo 1994; Kim et al. 1995; 
Krementsova et al. 1998; Rice and Mizuuchi 1995). Subdomain IIβ has a large, 
positively charged region exposed on its surface (Rice and Mizuuchi 1995). This 
participates in binding nonspecific DNA (including DNA that flank the cleavage site 
and target DNA) (Krementsova et al. 1998; Montano et al. 2012), is important at the 
transition between the strand-cleavage and strand-transfer steps of transposition 
(Krementsova et al. 1998), and has been implicated to in the metal-assisted assembly 
of the MuA tetramer and in intramolecular DNA strand transfer (Namgoong et al. 
1998).  
The C-terminal III domain contains two subdomains, IIIα and IIIβ. The IIIα subdomain 
has a role in transpososome assembly (Mariconda et al. 2000; Naigamwalla et al. 
1998); it binds DNA nonspecifically and contributes to the capture of target DNA 
(Montano et al. 2012). The IIIα subdomain also has cryptic nuclease activity which 
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might be involved in removing the flanking host DNA after initial integration (Choi 
and Harshey 2010; Montano et al. 2012; Wu and Chaconas 1995). Alternatively, this 
removal might also be accomplished by IIIα delivering the uncleaved strand into the 
catalytic site (subdomain IIα) for hydrolysis (Montano et al. 2012). The IIIβ subdomain 
is essential for interaction with the MuB and ClpX proteins (Levchenko et al. 1997; 
Wu and Chaconas 1994). Phage-encoded MuB is required for target capture during 
intermolecular transposition (Maxwell et al. 1987; Mizuno et al. 2013), and it also 
interacts with MuA to optimize all stages of transpososome assembly (Baker et al. 
1991; Mizuuchi et al. 1995; Surette et al. 1991). The host encoded ClpX protein is 
needed for the remodeling or disassembly of the transpososome after strand transfer 
and before replication (Levchenko et al. 1997).  
 Mu transposition complexes in different stages of transposition 
Bacteriophage Mu uses higher-order nucleoprotein complexes, or transpososomes, for 
transposition. Transpososomes contain the phage Mu genome synapsed by the MuA 
transposase proteins, and transpososome configuration varies through the different 
stages of Mu transposition (reviewed by Harshey 2014; Mizuuchi 1992).  
MuA is inactive as a monomer, and becomes chemically active only when bound to 
Mu ends and assembled into a tetrameric form (Baker and Mizuuchi 1992; Lavoie et 
al. 1991; Mizuuchi et al. 1992). Within the tetramer, the catalytic steps are conducted 
by only two of the MuA subunits, those bound to the L1 and R1 binding sites of Mu, 
while the other two subunits of the tetramer appear to be essential for the structural 
integrity of the transpososome (Mariconda et al. 2000; Namgoong and Harshey 1998; 
Williams et al. 1999). The catalysis of cleavage and strand transfer occurs in trans, i.e. 
with MuA bound to the left end and the catalysis reaction chemistry at the right end, 
and vice versa (Aldaz et al. 1996; Savilahti and Mizuuchi 1996).  
At an early stage in transpososome assembly, a three-site synaptic complex, LER, is 
formed between the left end, right end, and the enhancer (Watson and Chaconas 1996). 
In the LER complex, six MuA monomers are bound to L1-L3 and R1-R3 through their 
Iβµ domains, and interact with E through their Iα domain. The HU and IHF proteins 
both bend DNA and have important roles in the formation of LER. The interactions 
between MuA subunits in LER lead to the tetramerization of MuA and the formation of 
the stable functional core of subsequent complexes (Kobryn et al. 2002; Lavoie et al. 
1991). The paired Mu-end structure is held together by the MuA tetramer, which is 
bound only to the L1, R1, and R2 MuA-binding sites at the Mu ends (Kuo et al. 1991; 
Lavoie et al. 1991; Mizuuchi et al. 1991). Although the enhancer is not required for 
these chemical steps, it remains weakly associated with MuA also in tetrameric 
complexes.  
Interactions within the LER complex lead to the formation of more stable tetrameric 
complexes. The first type of tetrameric complex is type 0, also called a stable synaptic 
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complex (SSC) (Wang et al. 1996). In the type 0 complex, MuA assumes its active 
tetrameric configuration, but no strand cleavage has yet occurred. In the presence of 
Mg2+, single-strand cleavage occurs at both Mu ends, and the type 0 complex is 
converted into a type 1 complex, also called the cleaved donor complex (CDC) 
(Craigie and Mizuuchi 1987; Surette et al. 1987). The 3´-OH groups of the cleaved 
donor complex attack the target DNA in a direct transesterification reaction, which 
results in the formation of a type 2 complex, also called the strand-transfer complex 
(STC) (Surette et al. 1987). The type 2 complex is the most stable Mu transpososome. 
The strand-transfer reaction is assisted by MuB, which interacts with the C-terminus of 
MuA and affects the target-site selection (Harshey and Cuneo 1986; Leung and 
Harshey 1991; Maxwell et al. 1987). The resulting strand transfer product is a 
branched molecule, called the Shapiro intermediate or θ structure (Shapiro 1979), in 
which MuA is still intact. The MuA tetramer is disassembled by a host protein, ClpX 
(Kruklitis et al. 1996); in the replicative pathway, this action is followed by replication 
of Mu and leads to the formation of a cointegrate molecule.  
 Structure of Mu transposition complex 
Although the organization of almost all the individual MuA subdomains has been 
resolved by NMR or X-ray crystallization, the crystallization of the entire Mu 
transposition complex proved difficult and was accomplished only recently (Montano 
et al. 2012). The X-ray crystal structure contained a Mu strand-transfer transpososome, 
with a pair of Mu-ends derived from the Mu genome’s right end, each carrying two 
MuA binding sites, R1 and R2, a tetramer of truncated MuA proteins (residues 77-
605), and target DNA. An earlier electron-microscopy (EM) structure of the Mu 
transpososome (without the target DNA) had suggested a V-shape for the Mu R-ends 
and the MuA tetramer (Yuan et al. 2005), and the crystal structure was consistent with 
those findings. Specifically, it revealed a scissor-like configuration, in which the Mu 
end DNAs form the handles and the sharply bent target DNA the blades (Montano et 
al. 2012) (Figure 4.).  
Figure 4. X-ray crystal structure of Mu transpososome 
joined to target DNA. The structure contains a pair of Mu-
ends derived from the Mu genome’s right end, each 
carrying two MuA binding sites, R1 and R2 (pink and 
blue), tetramer of truncated version of MuA proteins 
(residues 77-605), missing the N (Iα)- and C (IIIβ)-
terminal domains, and target DNA (black). Magenta 
spheres depict scissile phosphates (only one can be seen 
in the picture). The figure is generated with PyMOL.  
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The crystal structure of the Mu transpososome confirmed many earlier results and 
predictions from biochemical studies and also provided new insights. For example, it 
was known that the MuA Iβ and Iγ subdomains are responsible for site-specific DNA 
binding at the Mu ends (Kim and Harshey 1995). The crystal structure revealed that, 
besides recognizing the specific sites, the R1-bound DNA-binding subdomains are also 
engaged in protein-protein contacts (Montano et al. 2012). The Iβ subdomain interacts 
with the IIα region of the subunit at the R2 site at the same Mu end, while the Iγ 
subdomain has contacts to the IIα region of the subunit at the R1 site at the other Mu 
end, as well as with subdomain IIIα of the subunit at the R2 site at the same Mu end 
(Montano et al. 2012).  
The crystal structure likewise shed light on the function of the IIα subdomain, which 
contains the catalytic site. Biochemical studies had shown that with Mu ends that contain 
the R1-R2 MuA binding sites, only the subunit at the R1 site provides the active site for 
catalysis, which happens in trans (Namgoong and Harshey 1998). The other subdomain 
of domain II, subdomain IIβ, was predicted to interact with the target DNA 
(Krementsova et al. 1998). The crystal structure of the Mu transpososome confirmed the 
results and predictions of these earlier biochemical studies (Montano et al. 2012), and, in 
addition, showed that the interaction between the IIβ subdomain and the target occurs 
only in the R1 subunit (Montano et al. 2012). Subdomains IIα and IIβ of the subunit at 
the R2 site bridge the Mu ends and have a mainly structural role (Montano et al. 2012).  
The X-ray structure also resolved the organization of the previously uncharacterized 
MuA IIIα subdomain (Montano et al. 2012). Like the other subdomains, IIIα has 
different roles depending on whether the subunit is bound to the R1 or R2 site. In the R1-
bound subunit, IIIα stabilizes the strongly bent target DNA. Target bending may help 
reduce reversion of the strand-transfer complex by straining the DNA conformation in 
such a way as to increase the distance between the Mu ends and the active site after 
strand transfer (Montano et al. 2012). Rearrangements at domain III of the R1 subunit 
after target capture may also allow the ClpX remodeling machinery to recognize the 
strand-transfer complex for disassembly (Montano et al. 2012). Instead, IIIα of the R2-
bound subunit is required for initial transpososome assembly (Mariconda et al. 2000). 
The crystal structure suggests that this subdomain wraps around the other subunits near 
the catalytic site and stabilizes the complex (Montano et al. 2012). The IIIα subdomain of 
the R2-bound subunit may also interact with the flanking host DNA and contribute to its 
cleavage after insertion into the target DNA (Montano et al. 2012).  
 Regulation of Mu transposition  
1.4.6.1 Control of lysogenic repression 
In the lytic state, phage Mu replicates highly efficiently through replicative 
transposition. However, during the lysogenic state, transposition can be shut down 
completely (reviewed by Toussaint et al. 1994). The key regulator in the establishment 
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of lysogeny is the Rep protein (product of the c gene), which can shut down Mu 
transposition functions. This repressor binds to an operator region (which overlaps the 
enhancer segment) and blocks the expression of early lytic genes, such as MuA and 
MuB (reviewed by Goosen and van de Putte 1987). Wild-type Mu lysogens are quite 
stable and are not induced by UV or any other known physical or chemical treatment. 
However, derivatives of Mu that have repressors sensitive to either high temperature or 
proteolytic degradation can be induced by high temperature or proteolysis by cellular 
proteases, respectively (Lamrani et al. 1999; Ranquet et al. 2005; Vogel et al. 1991). 
The inactivation of the repressor allows the expression of early lytic genes and 
replicative transposition of Mu.  
1.4.6.2 Quality control in transposition 
The assembly of Mu transpososomes is regulated at several levels (reviewed by Harshey 
2014; Mizuuchi 1992). An essential regulatory element is the enhancer segment, which 
has an important role in the regulation of early transpososome assembly prior to any 
irreversible chemical steps (Mizuuchi and Mizuuchi 2001; Watson and Chaconas 1996). 
The formation of the first transposition complex requires that the enhancer segment 
(which overlaps the operator sequence) is available and not bound by the Mu repressor 
protein Rep (Mizuuchi and Mizuuchi 1989; Mizuuchi et al. 1992). Rep shares homology 
in its DNA-binding domain with the enhancer-binding domain of MuA, and when bound 
to the operator site, Rep blocks transposition by blocking both MuA binding to the 
enhancer site and the transcription of early lytic genes (Craigie et al. 1984; Harshey et al. 
1985; Leung et al. 1989). Thus, Rep down-regulates transposition at two levels. The 
enhancer segment is also suggested to play a regulatory role in keeping the MuA 
monomer catalytically silent, in facilitating and stabilizing synapsis between ends, and in 
ensuring that the ends of the same Mu genome are paired, instead of the ends from 
neighboring genomes (reviewed by Harshey and Jayaram 2006). 
Transpososome assembly is also regulated by two other important features: “domain 
sharing”, i.e. a functional active site built from domains of different MuA monomers 
(Namgoong and Harshey 1998), and trans catalysis, with MuA bound to the left end 
and the catalysis reaction chemistry at the right end, and vice versa (Aldaz et al. 1996; 
Savilahti and Mizuuchi 1996). These two features ensure that the active site is 
functional only after multimerization of the MuA monomers, and that donor cleavage 
happens only after the two Mu ends have been synapsed and have formed a stable 
complex.   
 Mu target site selection 
Even though transposons can insert into various sites in the target DNA, they all appear 
to have at least some degree of target-site selectivity (reviewed by Craig 1997). Among 
transposons, the target-site selectivity of Mu is relatively low, with a target recognition 
site that is only 5bp long (5´-C-Py-(G/C)-Pu-G-3´, where Py is C or T, and Pu is A or 
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G) (Haapa-Paananen et al. 2002; Mizuuchi and Mizuuchi 1993). This sequence-level 
target site preference is encoded by MuA alone, independent of the MuB protein. 
MuB is a regulatory protein of the Mu transposon which assists in target site selection 
and in transposition immunity (Maxwell et al. 1987). It is an ATP-dependent 
nonspecific DNA-binding protein with ATPase activity. Upon ATP binding, MuB 
polymerizes and forms helical filaments around DNA (Greene and Mizuuchi 2004; 
Mizuno et al. 2013), with a modest tendency to form larger filaments on DNA with 
high A/T content (Greene and Mizuuchi 2004). MuA that is bound to the Mu ends 
induces ATP hydrolysis by MuB, which dissociates the MuB from DNA, thus 
generating regions without MuB, which are poor targets for new transposon insertions 
(Figure 5) (discussed in more detail in section 1.4.8.1) (Adzuma and Mizuuchi 1988; 
Maxwell et al. 1987). Conversely, the nucleotide-bound MuB stimulates the activity of 
MuA at several steps, including the formation of the MuA-Mu DNA complex and the 
nicking of Mu ends (Schweidenback and Baker 2008). The helical parameters of the 
MuB filament do not match those of the coated DNA, and MuB does not deform the 
DNA to which it is bound (Mizuno et al. 2013). However, the MuB-imposed symmetry 
model proposes that MuA and MuB together may induce a symmetry match between 
DNA and MuB at the MuB filament end and thus deformation of DNA, which results 
in target capture, as the bent DNA conformation is favored by MuA for transposition 
(Figure 5.) (Mizuno et al. 2013).    
 
Figure 5. Model for MuB function in target capture and cis immunity. Upon ATP binding MuB 
polymerizes and forms helical filaments around DNA. MuA bound to Mu ends induce the ATP 
hydrolysis by MuB, which dissociates the MuB from DNA and generates regions without MuB. 
Reciprocally, the nucleotide-bound MuB stimulate MuA to pair and nick Mu ends. According to 
Mizuno et al. 2013, MuA and MuB together may induce deformation of DNA at the boundary of 
MuB filament, which results to target capture. Drawn according to (Mizuno et al. 2013).  
 Mu transposition immunity  
Bacteriophage Mu and other transposons, including Tn7 and members of the Tn3 
family, avoid inserting near or into their own genome through a phenomenon called 
transposition immunity (reviewed by Craig 1997). For this purpose, Mu utilizes two 
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mechanisms, cis immunity and genome immunity, which operate outside and inside the 
Mu ends, respectively (Ge et al. 2010).  
1.4.8.1 cis immunity 
The cis-immunity mechanism prevents regions immediately outside the Mu ends from 
being used as targets by the element. This immunity can extend over large distances 
from the chromosomal site where the transposon is located, but does not provide 
protection to the whole bacterial genome harboring the transposon (Adzuma and 
Mizuuchi 1988; Adzuma and Mizuuchi 1989). A key component of the immunity 
mechanism involves MuB-MuA interactions. MuB-bound DNA is an efficient 
transposition target, but MuA bound to Mu ends interacts with nearby MuB-ATP 
complexes and induces the ATPase activity of MuB. This dissociates MuB from the 
nearby DNA before target-site commitment, making the region near the Mu ends a 
poor target for new insertions (Adzuma and Mizuuchi 1991; Greene and Mizuuchi 
2002a). The MuA-MuB interaction that removes MuB requires DNA looping between 
the binding sites of MuA and MuB, and as the loop increase in size over time it drives 
the transpososomes to distal target sites (Greene and Mizuuchi 2002b; Han and 
Mizuuchi 2010). MuA and MuB reciprocally stimulate each other’s enzymatic activity, 
such that their interactions can result in either cis immunity or target-site selection in 
trans. It is not clear what factors control the temporal order of these two outcomes, but 
they may be determined by the oligomeric state of MuA, e.g., whether MuA is only 
bound to Mu ends or already assembled into an active transpososome (Greene and 
Mizuuchi 2002b).  
1.4.8.2 Mu genome immunity 
Mu amplifies its DNA 100-fold during the lytic phase, and with each round there is a 
risk of Mu transposing into itself. The cis-immunity mechanism has been shown to be 
strongest around 5 kb outside the Mu ends (Manna and Higgins 1999), and thus is not 
expected to be capable of protecting the 37-kb Mu genome completely. Instead, a 
relatively new Mu genome-immunity mechanism has been described which functions 
inside the ends and protects Mu from self-integration (Ge et al. 2010). In contrast to the 
cis-immunity mechanism, in the genome-immunity mechanism MuB stays strongly 
bound within the Mu genome. According to the model for Mu genome immunity, the 
Mu genome is segregated into an independent chromosomal domain, in which 
polymerization of MuB on the genome forms a barrier against self-integration (Ge et 
al. 2010). Mu genome immunity could theoretically be functionally similar to the 
immunity mechanism of the Moloney Murine Leukemia Virus (MoMLV) which 
utilizes the barrier-to-autointegration factor (BAF) to protect itself from self-
integration (Lee and Craigie 1994; Lee and Craigie 1998). BAF prevents 
autointegration by compacting the viral DNA and making it inaccessible as a target for 
integration (Bradley et al. 2005; Zheng et al. 2000).  
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 Transposon tools 
Transposons are powerful tools for investigating and manipulating genes and genomes, 
and they have been utilized widely in many applications for advanced genetic studies 
(reviewed by Boeke 2002; Hayes 2003). A variety of transposon tools has been 
successfully used in different organisms, including prokaryotes, plants, invertebrates, 
and recently also vertebrates (reviewed by Hayes 2003; Ivics et al. 2009; Ivics and 
Izsvak 2010; Ni et al. 2008). In the transposition process, the transposon catalyzes its 
own insertion into a target site, which make transposons natural DNA delivery 
vehicles. They are extremely suitable for a number of different purposes, as the DNA 
between the transposon ends can be of any origin and can include useful features such 
as selectable markers, unique primer binding sites, reporter functions (such as the gene 
for β-galactosidase), plasmid origins of replication, and controlling elements (such as 
regulated promoters). 
Traditionally transposition applications were performed in vivo, which requires either 
mobilization of an endogenous transposon or the introduction into the host cell, via 
transformation or bacterial mating, of a plasmid (or plasmids) containing the 
transposon and transposase. The use of transposons in in vivo reactions can be 
complicated by different factors, such as the restricted host ranges of different 
elements.  
Host range limitations can be avoided by the use of in vitro transposition reactions. A 
number of efficient in vitro systems have been established both for prokaryotic and 
eukaryotic transposons. Examples of prokaryotic transposons include the in vitro 
reactions of Tn3 (Maekawa et al. 1996), Tn5 (Goryshin and Reznikoff 1998; Goryshin 
et al. 2000), Tn7 (Bainton et al. 1993), Tn10 (Chalmers and Kleckner 1994), Tn552 
(Leschziner et al. 1998), IS911 (Polard et al. 1996), and bacteriophage Mu (Haapa et 
al. 1999b; Mizuuchi 1983). Examples of eukaryotic transposons include the in vitro 
transposition system of yeast, Ty1 (Devine and Boeke 1994); the mariner/Tc1 family 
transposons Tc1 (Vos et al. 1996), Himar1 (Lampe et al. 1996), and Mos1 (Tosi and 
Beverley 2000); piggyBac (Mitra et al. 2008); and the hAT superfamily transposon 
Hermes (Zhou et al. 2004).  
Increased understanding of transposition mechanisms has facilitated the use of 
transposable elements for research purposes and enabled the establishment of efficient 
transposon tools for a variety of applications, including insertional mutagenesis 
(Dupuy et al. 2005; Lamberg et al. 2002), the generation of induced pluripotent stem 
cells (Woltjen et al. 2009), and functional genomics studies (Kekarainen et al. 2002; 
Miskey et al. 2005). In addition, transposon tools are increasingly being developed for 
gene therapy (Ivics and Izsvák 2006; VandenDriessche et al. 2009) and transgenesis 
applications (Ivics et al. 2009; Ivics and Izsvak 2010).  
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 Mu as a genetic tool 
The minimal Mu transposition system displays high transposition frequency and 
relatively low target-site selectivity (Haapa et al. 1999b; Haapa-Paananen et al. 2002), 
and these features make it ideal for a variety of applications. In addition, the Mu 
transposon ends can be designed to contain nucleotide changes outside of the MuA 
recognition sequence (Jones 2005; Poussu et al. 2004), which can be exploited when 
designing novel Mu tools. Mu in vitro transposition technology has been used for DNA 
sequencing (Haapa et al. 1999a), protein engineering for structure/function studies 
(Baldwin et al. 2008; Edwards et al. 2008; Jones 2005; Poussu et al. 2004; Poussu et al. 
2005), genome-wide functional mapping of virus genomes (Kekarainen et al. 2002; 
Kiljunen et al. 2005; Krupovic et al. 2006; Vilen et al. 2003), construction of gene 
targeting vectors (Jukkola et al. 2005; Turakainen et al. 2009; Vilen et al. 2003; Zhang 
et al. 2005), insertional mutagenesis of archaea (Kiljunen et al. 2014), and SNP 
discovery (Orsini et al. 2007; Yanagihara and Mizuuchi 2002). In addition, functional 
transpososomes can be pre-assembled in vitro and subsequently transformed into host 
cells, where DNA of interest can be transposed in vivo into the genome of the recipient 
cell (Lamberg et al. 2002; Pajunen et al. 2005). This combination of in vitro and in vivo 
systems can be used for highly efficient, species-non-specific gene delivery and 
insertional mutagenesis, as demonstrated with a variety of Gram-negative and Gram-
positive bacteria, yeast, and mammalian cells (Lamberg et al. 2002; Paatero et al. 2008; 
Pajunen et al. 2005; Tu Quoc et al. 2007; Wu et al. 2009). The current applications for 
Mu in vitro transposition technology are presented in Table 2.  
1.5.1.1 DNA Sequencing 
The Mu-mediated sequencing approach enables the efficient and easy creation of 
sequencing templates (Haapa et al. 1999a). In this protocol, the transposon is integrated 
in vitro into the target plasmid DNA to be sequenced. Following re-introduction of the 
transposition products into bacterial cells, the cells are selected using an antibiotic-
resistance marker carried by the transposon to identify clones with transposon 
insertion. From the selected clones, sequencing is carried out bi-directionally using 
primers specific for the ends of the transposon. Mu-based sequencing product is 
commercially available from Thermo Fisher Scientific (TGS, Template Generation 
System). Recently, Mu transposition technology was also adapted for the generation of 
genomic DNA libraries using next-generation sequencing systems (Thermo Fisher 
Scientific, MuSeek library preparation kit). This method utilizes MuA transposase and 
Mu ends to simultaneously fragment the target DNA and tag the fragment ends with 
transposon DNA. In a subsequent reaction, fragments with transposon sequence tags at 
the ends are attached to platform-specific adapter sequences and PCR amplified, then 
subjected to high-throughput sequencing. A similar Mu-mediated strategy has also 
been used for monitoring outcome in gene therapy; to directly map the integration sites 
of therapeutic vectors using DNA barcoding and pyrosequencing (Brady et al. 2011).  
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1.5.1.2 Functional and structural studies of proteins 
Mu-based protein engineering applications can be used for functional and structural 
studies of proteins. In the pentapeptide insertion mutagenesis strategy, an in vitro Mu 
transposition reaction is utilized to produce random transposon insertions into a target 
plasmid containing the gene of interest (Poussu et al. 2004). Custom-designed 
transposon ends contain NotI sites, which enables the removal of the transposon core 
sequence. Self-ligation of digested clones results in a 15-bp insertion in the target 
DNA, and when the transposon is inserted in protein-coding regions, the 15-bp 
insertion encodes five additional amino acids. This system can be used, for example, to 
screen important sites for protein-protein interactions. Based on this strategy, a 
commercial product from Thermo Fisher Scientific is available for the construction of 
linker scanning libraries (MGS, Mutation Generation System). To enable the analysis 
of a whole mutant library en masse, without the need to construct or isolate mutants 
separately, pentapeptide insertion mutagenesis can be combined with yeast two-hybrid 
screening and PCR-based genetic footprinting (Pajunen et al. 2009).  
With the gene truncation strategy, a Mu in vitro transposition reaction is utilized to 
produce N- and C-terminal deletion variants of proteins for functional studies (Poussu 
et al. 2005). To produce C-terminal deletion variants, the transposon has been designed 
to contain translational stop codons in all three reading frames close to each transposon 
end. Therefore, protein translation is terminated near the transposon insertion site, and 
the resulting protein variants are truncated at their C-termini. To produce N-terminally 
truncated protein variants, the transposon is designed to contain a NotI site at each end. 
In this strategy the plasmid vector has to contain unique NotI restriction site 5´from the 
cloned target. Following digestion with NotI, the 5´-distal part of the target gene and 
the transposon core is eliminated, which generates N-terminally truncated versions of 
the target protein. Both N- and C-terminal protein variants are useful, for example, in 
mapping regions involved in protein-protein interactions.  
Mu in vitro transposition can also be used to generate novel molecular diversity and 
construct directed evolution libraries. In a method called triplet nucleotide removal, a 
Mu in vitro transposition reaction is utilized to introduce triplet nucleotide deletions at 
random positions throughout a target gene (Jones 2005; Simm et al. 2007). This 
method makes use of a Mu transposon that contains sites for the restriction enzyme 
MlyI at both ends, with the recognition sites placed 1 bp away from the site of 
transposon insertion. MlyI is a type IIS restriction enzyme that cuts 5 bp outside its 
recognition sequence to generate a blunt end. Transposition results in a 5-bp target-site 
duplication, and digestion with MlyI results in the removal of the transposon and 4 bp 
of the target gene at both ends. Ligation of the ends rejoins the target gene and results 
in a 3-bp deletion. Triplet nucleotide removal can be followed by replacement with a 
random 3-bp segment (the trinucleotide exchange method, TriNEx) (Baldwin et al. 
2008), or with a new protein domain (the domain insertion strategy; Edwards et al. 
2008). The trinucleotide removal, trinucleotide replacement, and domain insertion 
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methods are efficient approaches for generating novel molecular diversity for the 
construction of directed evolution libraries. 
1.5.1.3 Functional genetics and genomics of viruses 
Mu in vitro transposition technology can also be used for functional genetics and 
genomics studies of viruses. A method for the characterization of complete 
bacteriophage genomes exploits direct in vitro integration of transposon DNA into the 
target viral genomic DNA, without prior cloning of the viral genome (Kiljunen et al. 
2005; Krupovic et al. 2006; Vilen et al. 2003). Following electroporation into 
susceptible host cells, the mutant viruses are selected for their ability to form plaques. 
Determination of the transposon integration sites enables mapping of essential and 
nonessential regions and genes for virus propagation. An alternative version of the 
strategy, which utilizes cloned versions of virus genomes or genome segments as 
targets, has been used with RNA viruses to mutagenize both a genome segment 
(Laurent et al. 2000) and an entire RNA virus genome (Kekarainen et al. 2002).  
1.5.1.4 Construction of gene-targeting vectors 
Mu transposons can be used as tools for the construction of different kinds of gene-
targeting vectors in order to modify the mammalian genome, including vectors that can 
be used for generating null, hypomorphic, or conditional alleles (Jukkola et al. 2005; 
Turakainen et al. 2009; Vilen et al. 2003; Zhang et al. 2005). Compared with 
conventional methods for the generation of targeting constructs, which often require 
complex DNA manipulations, transposon-based methods are fast and technically 
straightforward. With a transposon-based strategy, several constructions aimed at 
targeting different exons can be generated simultaneously, and the procedure does not 
require restriction enzyme sites on genomic DNA near the exon of interest. A strategy 
for the generation of conditional knock-out gene-targeting vectors employs two 
successive transposition reactions to introduce a loxP site on one side of the exon of 
interest and on the other side, an antibiotic-resistance cassette (selectable both in 
bacteria and mammalian cells) flanked by loxP and FRT sites (Turakainen et al. 2009). 
Targeting constructions are linearized before electroporation into mouse embryonic 
stem cells, and desired clones resulting from homologous integration events undergo 
both positive and negative selection. FRT sites enable the removal of the resistance 
cassette by Flp-mediated recombination, and Cre-mediated recombination between the 
loxP sites enables the inactivation of the targeted gene.  
1.5.1.5 Insertion mutagenesis strategy for archaea 
The genetic basis of many unique archaeal features has yet to be well characterized, 
and studies have been hampered by a lack of efficient genetic screens. A recently 
established Mu transposition-based strategy provides the means for generating a 
random genomic insertion mutant library for archaea, as has been shown with 
Haloferax volcanii (Kiljunen et al. 2014). This insertion mutagenesis strategy 
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combines a Mu in vitro DNA transposition reaction and homologous-recombination-
based gene targeting in an archaeon (Kiljunen et al. 2014). The archaeal DNA is first 
digested and used as a target in an in vitro Mu transposition reaction. From the 
transposition products, fragments of the desired sizes are cloned into a suitable vector 
to yield a plasmid library. Inserts are released by digestion and transformed into 
archaeal cells to generate a transposon insertion mutant library. The library can then be 
used for the identification of non-essential genes. 
1.5.1.6 Mapping single nucleotide polymorphism 
The preference of Mu for targeting single-nucleotide mismatches can be exploited to 
map single-nucleotide polymorphism (SNP) (Yanagihara and Mizuuchi 2002), as has 
been demonstrated with a butterfly genome (Orsini et al. 2007). PCR amplification of a 
genomic region that contains at least two alleles located at the same position generates 
DNA duplexes that contain mismatches. With this DNA as a target, nearly 90% of the 
transposon insertions occur at the mismatched sites (Yanagihara and Mizuuchi 2002). 
Single-nucleotide polymorphisms are an important resource for providing genetic 
markers for the mapping of human disease genes, as well as for other studies, and Mu 
mismatch-targeting provides a simple method for detecting mismatches in DNA and 
isolating SNP markers from as-yet uncharted genomes (Orsini et al. 2007; Yanagihara 
and Mizuuchi 2002).  
Table 2. Applications for Mu in vitro transposition technology 
Use Application References 
DNA sequencing Creation of sequencing templates Haapa et al. 1999a, Brady et al. 2011 
Functional and structural 
studies of proteins 
Pentapeptide insertion 
mutagenesis strategy 
Poussu et al. 2004, Pajunen et 
al. 2009 
Gene truncation strategy Poussu et al. 2005 
Triplet nucleotide removal method Jones et al. 2005, Simm et al. 2007 
Trinucleotide exchange method, 
TriNEx 
Baldwin et al. 2008 
Domain insertion strategy Edwards et al. 2008 
Functional genetics and 
genomics of viruses 
Whole genome analysis of 
bacteriophages 
Vilen et al. 2003, Kiljunen et al. 
2005, Krupovic et al. 2006,  
Analysis of genomic regions 
and entire genomes of viruses 
cloned on specific vectors 
Laurent et al. 2000, Kekarainen 
et al. 2002 
Construction of different 
kinds of gene targeting 
vectors 
Generation of null, 
hypomorphic, or conditional 
alleles 
Jukkola et al. 2005, Turakainen 
et al. 2009, Vilen et al. 2003, 
Zhang et al. 2005 
Mapping single nucleotide 
polymorphism (SNP) 
Mismatch targeting Yanagihara and Mizuuchi 2002, 
Orsini et al. 2007 
Identification of non-
essential archaeal genes 
Generation of random genomic 
insertion mutant library for 
archaea 
Kiljunen et al. 2014 
Species non-specific gene 
delivery and insertional 
mutagenesis 
Use of in vitro pre-assembled 
transpososomes for gene 
delivery in vivo 
Lamberg et al. 2002, Pajunen et 
al. 2005, Paatero et al. 2008, Tu 
Quoc et al. 2007, Wu et al. 2009 
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2 AIMS OF THE STUDY 
This work focuses on the establishment of novel Mu transposition-based molecular 
genetics tools and the generation of MuA transposase variants with altered 
transposition frequency. Transposon-based applications are widely utilized in 
molecular biology, and the aim of this study was to add useful tools to the 
biotechnology toolbox by providing both a general test to measure the specific activity 
of transposition complexes and a cloning strategy for replication-deficient circular 
DNA. An additional goal was to improve Mu in vitro transposition applications by 
generating hyperactive MuA transposase variants.  
The specific aims were: 
1.  To generate a general-purpose assay to measure the activity measurement of 
DNA transposition complexes, using phage Mu transposition as a test platform. 
2.  To develop a method for MuA-mediated in vitro cloning of circular DNA, 
establish reaction conditions that reduce autointegration, and test the effect of 
MuB on reducing autointegration.  
3.  To generate and characterize various Mu-transposons with different origins of 
replication for MuA-mediated in vitro cloning of circular DNA, and test the 
effect of the simultaneous use of two transposons on reducing autointegration. 
4.  To generate hyperactive MuA tranposase variants, characterize their properties 
in the context of the Mu transpososome, and tailor specific MuA variants for 
different Mu-based applications.   
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3 MATERIALS AND METHODS 
The bacterial strains, plasmids, transposons, and oligonucleotides used in this study are 
described in the original publications.  
 In vitro transposition reaction 
Minimal Mu in vitro transposition reactions were conducted that contained only the 
MuA transposase protein, transposon DNA, and target DNA in standard reaction 
conditions as described in (Haapa et al. 1999b; Savilahti et al. 1995) (Studies I, II, III, 
and IV). As specified in each experiment, reactions contained variable amounts of 
transposon DNA as well as target DNA. Some reactions also contained competitor 
DNA or MuB (Study II). 
Reactions were stopped by the addition of 1% SDS (Studies II and III), by freezing in 
liquid nitrogen (Study IV), or by incubation at 75˚C (Study I). Reaction products were 
transformed into competent cells by heat shock (Studies I and IV) or by electroporation 
(Studies II, III, and IV). Following transformation, cells were grown briefly and then 
spread onto appropriate selection plates. 
 Transpososome pre-assembly 
Transpososomes were pre-assembled in vitro as described in (Lamberg et al. 2002; 
Pajunen et al. 2005) (Studies I and IV). Successful transpososome assembly was 
verified using agarose/BSA/heparin gels as previously described (Lamberg et al. 2002). 
Transpososomes were either used directly (Study IV) or further concentrated using 
polyethylene glycol (PEG 6000) precipitation as described in (Pajunen et al. 2005; 
Savilahti and Bamford 1993) (Study I). 
The pre-assembled transpososomes were used either for genomic integrations in vivo 
(Study IV) or as donor DNA for in vitro transposition reactions (Study I). Differently 
from the in vitro assay, in the in vivo assay, pre-assembled transpososomes encounter 
Mg2+ ions and thus become active only after electroporation into the E. coli cells.   
 Generation of MuA mutant libraries 
The MuA gene was mutated using error-prone PCR as described in (Rasila et al. 2009) 
with the specifications described in study IV. Taq DNA polymerase was used under three 
mutagenic PCR conditions (0, 1, or 2 μl of mutagenic buffer added in the standard 50-μl 
reaction) and Mutazyme II DNA polymerase was used in two separate PCR reactions (5 
or 10 cycles of amplification). A total of five MuA mutant libraries were generated. 
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 Papillation assay 
The transpositional activity of MuA transposase variants was determined using a 
papillation assay as described in (Pajunen et al. 2010) (Study IV). The standard assay 
included incubation at 30˚C for 115 h on LB agar plates that were supplemented with 
Ap (100 µg/ml), Cm (20 µg/ml), lactose (0.05%), X-gal (40 µg/ml), and arabinose 
(1×10-4%). The papillation assay is based on mini-Mu transposon mobilization in vivo. 
The mini-Mu transposon contains cat gene for chloramphenicol selection, and reporter 
gene lacZ, lacking the codons for amino acids 1-8. Transposition into any expressed 
chromosomal gene downstream of a promoter results in activation of the lacZ gene and 
thereby formation of blue microcolonies (papillae) growing on otherwise whitish E. 
coli colonies. The mean value and standard deviation (SD) of the number of papillaes 
were calculated for each protein variant from six colonies.  
 Mutant variant sequence determination 
The mutated residues within the MuA gene of each particular plasmid were defined by 
sequence analysis. DNA sequencing was done at the DNA sequencing facility of the 
Institute of Biotechnology, University of Helsinki. 
 Protein expression and purification 
MuA transposase proteins were expressed in BL21(DE3)pLysS using pET3d-derived 
plasmids, and purified with phosphocellulose and hydroxylapatite columns by employing 
a procedure described in (Baker et al. 1993), with modifications described in Study IV. 
Protein concentration was determined spectrophotometrically using the A280 value of 
1.58 = 1 mg/ml (Baker et al. 1991). The purity level of the protein preparations was 
examined in two ways: with excessive protein loading on an SDS-PAGE gel to determine 
the number of protein species, and with prolonged incubation under in vitro reaction 
conditions with supercoiled plasmid DNA to examine the level of nuclease activity.  
 Structural analyses 
The structural and functional consequences of mutations were assessed by 
investigating the variations within the secondary and tertiary structures of MuA 
proteins and Mu transpososomes (Study IV). The NMR and X-ray structures for 
isolated MuA protein domains, and the transpososome crystal structure, were from the 
Protein Data Bank (PDB) (Berman et al. 2000). The dictionary of protein secondary 
structure (DSSP) was used for secondary structural element identification (Shockett 
and Schatz 1999). UCSF Chimera (Pettersen et al. 2004) and PyMOL (The PyMOL 
Molecular Graphics System Version 1.3) were used for visualizations.  
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4 RESULTS AND DISCUSSION 
 Activity measurement of DNA transposition complexes (I) 
Traditionally, DNA transposition activity or the quality of DNA transposition 
complexes has been monitored by utilizing in vitro transposition reactions with a 
plasmid target. To score transpositional activity, i.e. transposon integration events into 
target plasmids, the transposition reaction products are introduced into E. coli cells, 
and selected simultaneously for transposon and target plasmid resistance markers. 
However, this type of measurement is dependent on resistance markers and thus 
limited to transposons with suitable bacterial markers. This method cannot be used to 
measure the activity of transposons without selectable markers and those constructed 
solely for eukaryotic use. Furthermore, it is not ideal to use selection that depends on 
the marker carried by each particular transposon when comparing the activities of 
different transposons. Therefore, to standardize measurements of transpositional 
activity, we developed a general activity measurement assay for DNA transposition, 
and used Mu transposition as a test platform. We also characterized the properties of 
the assay for a set of Mu transposons, including its linear response as a function of 
transposon DNA concentration and its response as a function of E. coli competency. 
The established assay can be used to directly compare transpososome activities with all 
types of mini-Mu transposons, and it should be also directly applicable to other 
transposition-based systems with a functional in vitro reaction.  
 Activity measurement assay standardizes the measurement of transpositional 
activity regardless of the specific nature of transposon employed 
The developed assay is based on an in vitro transposition reaction with a pZErO-2 
target plasmid that carries a lethal ccdB gene (Bernard et al. 1994; Bernard and 
Couturier 1992; Invitrogen by Life Technologies 2012). Expression of the CcdB 
protein in wild-type E.coli is lethal to the cells, but if transposition targets ccdB, this 
gene becomes inactivated and cells that have received such plasmids survive (Principle 
of the assay design in Figure 1 in I). As the assay is not dependent on the marker gene 
carried by the transposon, it is well-suited for all types of transposons, including those 
that do not contain selectable marker genes or contain markers that are functional only 
in eukaryotic cells. We characterized the properties of the assay with three mini-Mu 
transposons: Cat-Mu (size 1.3 kb, encodes chloramphenicol-resistance marker), 
Kan/Neo-Mu (size 1.9 kb, encodes kanamycin-resistance marker) and Puro-eGFP-Mu 
(size 2.1 kb, no antibiotic resistance marker for bacteria) (Figure 2 in I). To enable 
transpososome assembly, transposons were incubated with MuA protein for different 
periods of time (0, 10, 60, 120, or 240 minutes). Pre-assembled transposition 
complexes were incubated in vitro with the pZErO-2 target plasmid (carries the ccdB 
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gene and a kanamycin-resistance marker) and transposition reaction products were 
transformed into competent E. coli cells and plated on kanamycin selection plates to 
score integration events into target plasmids. All three transposons yielded very similar 
results (Figure 2 in I), regardless whether the transposition events were selected toward 
antibiotic marker encoded by the transposon in addition to the ccdB gene, or solely by 
the ccdB gene. This illustrated the assay’s suitability for various types of transposons 
and especially for transposons that entirely lack selection markers.  
However, we noticed that the assembly of transposition complexes with the longer 
transposons Puro-eGFP-Mu (2.1 kb) and Kan/Neo-Mu (1.9 kb) was somewhat slower 
than that with the shorter transposon Cat-Mu (1.3 kb). Similar decrease in transposition 
efficiency with increased transposon length has been reported with several transposons, 
including Mu (Wei et al. 2010; Chandler et al. 1982; Way and Keckner 1985; Lampe et 
al. 1998; Izsvak et al. 2000). Since the transposons that we used in this study were all 
relatively short, further studies would be warranted with appropriate sets of longer 
transposons to draw any further conclusions on the effect of transposon length. For 
future studies it would also be interesting to use the assay to directly compare the 
transposition activity of different transposon species, for example, Tn5 and Mu.   
 Operational range of the activity measurement assay 
We defined the operational range of the assay by using different quantities of Cat-Mu 
transposition complexes (from 40 to 520 ng of transposon DNA per in vitro 
transposition reaction) (Figure 3 in I). The number of colonies increased linearly with 
the amount of transposon DNA, and reliable activity measurements were obtained even 
with a small amount of transpososomes. These results showed that the assay was 
adjustable with a wide range of DNA concentrations.  
 Influence of competence status for the activity measurement assay 
The competence status of recipient E. coli cells is known to influence the number of 
colonies produced following the transformation of in vitro transposition reaction 
products into competent cells. To determine the effect of variation in competence 
status on the activity measurement assay, we transformed in vitro transposition reaction 
products into different batches of competent DH10B E. coli cells (Figure 4 in I). As 
expected, the number of colonies correlated linearly with the competence status of the 
E. coli cells, which enables normalization and comparison of results obtained with 
different cell batches. We used heat-shock transformation into chemically competent 
cells in our experiments, but the reaction products could as well have been 
electrotransformed into electrocompetent cells. However, with electrotransformations, 
the variation between transformations could have been greater.  
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In summary, this study describes a very useful assay to measure DNA transposition 
activity regardless of the specific nature of the transposon. In particular, the assay is 
aimed to ease the evaluation of transposons containing only eukaryotic markers and 
transposons without selectable markers. We hope that the established assay will serve 
as a dependable quality control measure for various applications of in vitro DNA 
transposition technology, including also future transposition-based tools.  
 MuA-mediated in vitro cloning of circular DNA (II, III) 
Circular DNA is abundant in nature and DNA circles are involved in many natural 
processes. Therefore, characterization of such molecules and studies on their functions 
are important and expected to provide new insights as well as novel concepts with 
regard the biology of living systems. However, discovery and analysis of these circles 
is sometimes hindered by their relatively low quantity and lack of selectable markers. 
In such cases cloning provides an alternative means to produce sufficient amounts of 
material for DNA analyses. In transposition-aided cloning, replication-deficient DNA 
circles are transformed into plasmids which are able to replicate in E. coli. So far, Tn5 
and Tn552 systems have been utilized for this process (Agron et al. 2002; Jendrisak et 
al. 2002; Kirby et al. 2002). The method enables simultaneous selection for circular 
DNA and against linear fragments. Also, the circular form of the target is retained 
throughout the procedure, as no double-strand breaks are introduced during the 
transposition reaction. Here, we established a strategy to clone circular DNA based on 
the Mu in vitro transposition reaction (II), and constructed ten novel transposons in 
order to enable several approaches (II, III). In addition, we examined the effect of 
substrate stoichiometry (II), and determined the sensitivity of the methodology with 
decreasing target amounts (II). In addition, to study novel approaches for the reduction 
of intramolecular transposition, we tested the effect of MuB and BAF (II), and the 
simultaneous use of two transposons (III) on the transposition reaction product profile. 
Our results delineate the parameters that affect the reaction product profile, define the 
minimum amount of circular target DNA required, and provide guidelines for the 
efficient utilization of the strategy.  
 Overview of the MuA-mediated cloning method and characteristics of the 
target plasmids (II, III)  
The established method utilizes an in vitro transposition reaction with a custom-
designed transposon in order to deliver both a selectable marker and an E. coli plasmid 
replication origin into the target plasmids (Principle of the assay design in Figure 1 in 
II). The transposon insertion generates replication-competent target plasmids following 
the recovery of recombinants by transformation into E. coli. As target plasmids, we 
used the conditionally replication-deficient plasmids pALH31 (II, III) and pLOI2227 
(III). The pALH31 plasmid encodes a kanamycin-resistance gene and contains the 
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R6Kγ replication origin, which makes it replication-deficient in standard E. coli strains. 
The pLOI2227 plasmid encodes a kanamycin-resistance gene and contains the 
temperature-conditional pSC101 replication origin, which makes the plasmid 
replication-deficient when grown at 42˚C. We used both of these target plasmids as 
stand-ins for a replication-deficient DNA circle.  
 Construction of novel mini-Mu transposons (II, III) 
To provide a new set of tools for establishing diverse DNA circles in E. coli, we 
constructed altogether ten novel mini-Mu transposons (Figure 1 in II and Figure 2 in 
III). This transposon set includes five pairs, with each pair containing one of five 
replication origins, and the members of a pair differing only in the presence or absence 
of a chloramphenicol-resistance gene (cat). The following five replication origins were 
used: p15A, R6Kγ, pUC-ori, F-ori, or P1-ori. These differ greatly in their copy 
numbers per cell, which vary from low (only 1-2 copies per cell) to high (several 
hundred per cell; Table 2 in III). The optimal choice of the replication origin may 
depend on the study approach and on a variety of factors, such as, will there be several 
plasmid types in a cell at the same time and how many copies of the molecule per cell 
is desired.  
 MuA-mediated transposition can be used to clone circular DNA molecules 
(II, III) 
The feasibility of the method was first evaluated by performing in vitro transposition 
reactions with the Ori(pUC)-Cat-Mu transposon and the pALH31 target plasmid. The 
results showed that the MuA-mediated cloning method was capable of converting the 
target DNA molecules into plasmids which were able to replicate in a standard E. coli 
strain (Table 2 in II). In addition, we were able to clone circular DNA from very low 
target amounts despite the presence of contaminating linear DNA fragments (Table 3 
in II). In study III, nine novel transposons, containing five different replication origins, 
were shown to be functional for the cloning of circular DNA (Table 3 in III). Together 
these ten novel transposons represent a comprehensive set of tools for establishing 
diverse DNA circles in E. coli. We expect that all of the constructed transposons are 
able to facilitate the replication of plasmids at least up to 10 kb in size, and the 
transposons containing P1 and F origins to be able to convert even up to 300 kb sized 
circles into E. coli compatible replicons. However, as we used only small target 
plasmids (~3 kb) in our experiments, the cloning system is yet to be tested with larger 
target molecules.  
 Intramolecular transposition generates background colonies (II, III) 
Intramolecular transposition (also called autointegration) is a phenomenon in which a 
transposon integrates into itself. In standard transposon reactions the intramolecular 
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transposition products will not form replication-competent circles due to the lack of the 
origin of replication. With transposons that contain both a replication origin and 
selectable marker, autointegration products can generate circles that do not contain the 
external target DNA but are still replication-competent in E. coli. Such molecules yield 
background colonies on selection plates which do not contain the target of interest. 
With our experimental set-up, we were able to determine the ratio between 
intramolecular and intermolecular reaction products by selecting towards transposon 
and target plasmid (chloramphenicol and kanamycin or kanamycin only) or towards 
transposon only (chloramphenicol) and enumerating bacterial colonies on selection 
plates. We noticed that, although we were able to score high numbers of colonies 
representing intermolecular transposition events into the target plasmid, we obtained 
even higher numbers of colonies that were only chloramphenicol resistant (Table 2 in 
II). This meant that the majority of colonies did not contain the target of interest. The 
most logical explanation for these chloramphenicol resistant colonies was 
intramolecular transposition, although they could also be gained via in vivo 
circularization of the transposon or illegitimate integration into the host genome. We 
tested this by incubating reactions without MuA and selecting against chloramphenicol 
(Table 2 in II). Some chloramphenicol colonies could be detected, but as most, if not 
all of them were also ampicillin resistant (data not shown), it indicated that they were 
produced by transposon carrier plasmids. Such contaminants can follow from 
transposon DNA preparations and are fairly common.  We could therefore conclude 
that the intramolecular transposition was the main mechanism producing the colonies 
that did not contain the target plasmid.  
 Reaction product profiles with different donor/target ratios provide the 
means to predict the success rate in cloning (II) 
The effect of the donor/target ratio on the frequency of intramolecular transposition has 
not been systematically studied in any transposon system. Therefore, to study the ratio 
of intra- versus intermolecular reaction products, we conducted in vitro transposition 
reactions with different amounts of Mu transposon and target DNA (Figure 2 and 
Table 3 in II). These results can be used to estimate the number of clones needed for 
the screening of correct clones under different donor/target ratios. Overall, the results 
demonstrated that when the amount of target DNA was increased relative to donor 
DNA, the transposon inserted more frequently into the external target. As a radical 
reduction in the transposon DNA is not feasible, intramolecular transposition 
unavoidably dominates when the amount of target DNA is limited. Although the effect 
of donor/target ratio has not been thoroughly studied prior to this, it was the major 
factor affecting the frequency of intramolecular transposition also in previous studies 
with Tn5- and Tn552-based cloning applications (Agron et al. 2002; Jendrisak et al. 
2002; Kirby et al. 2002; Wang et al. 2010).  
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 Reducing the amount of intramolecular transposition (II, III) 
In previous studies of transposition-based cloning applications, intramolecular 
transposition was reduced by the utilization of excess target DNA and by the 
enrichment of intermolecular transposition products via preparative agarose gel 
electrophoresis (Agron et al. 2002; Jendrisak et al. 2002; Kirby et al. 2002). However, 
this approach requires that the amount of target DNA is already present at sufficient 
levels, and gel enrichment demands that the expected intramolecular and 
intermolecular transposition products are sufficiently different in size as to allow 
separation. In order to design novel approaches for the reduction of intramolecular 
transposition, we tested the effects of MuB and BAF (II), as well as the simultaneous 
use of two transposons (III) on the transposition reaction product profile.  
4.2.6.1 MuB can be used to reduce intramolecular transposition (II) 
MuB is a Mu-encoded regulatory protein that provides target immunity by directing 
transposition into distant target sites (Adzuma and Mizuuchi 1988; Adzuma and 
Mizuuchi 1989; Ge et al. 2010). We examined whether MuB could be used to reduce 
the frequency of intramolecular transposition in our system (Figure 2 in II). MuB 
mediated immunity has been observed both with circular supercoiled donor DNA 
molecules and, to a somewhat weaker extent, linearized donors (Adzuma and Mizuuchi 
1988). The achivement of maximum immunity required the presence of all six natural 
MuA-binding sites in the transposon ends (L1-L3 and R1-R3) (Adzuma and Mizuuchi 
1988). Donor molecules with transposons that contained only sites R1 and R2 at both 
ends exhibited weak but significant immunity (Adzuma and Mizuuchi 1988). In our 
study, we utilized a linear transposon with a pre-cut configuration and the R1 and R2 
MuA-binding sites at each end. In order to maximize our potential effect size, the 
donor/target ratio was deliberately adjusted to 10:1. Two MuB concentrations were 
tested, 600 nM and 1200 nM, which both clearly reduced the frequency of 
intramolecular transposition compared to the reaction without MuB (Figure 2 in II). 
Our results showed that with the set-up used MuB did not completely eliminate 
intramolecular transposition, but it nevertheless increased the fraction of intermolecular 
transposition. This indicated that MuB promoted Mu integration into target DNA that 
did not contain a Mu end.  
4.2.6.2 BAF cannot act as an effective barrier to autointegration factor in a MuA-
mediated in vitro transposition reaction (II and this thesis) 
A different mechanism for generating self-immunity has been characterized in 
retrovirus integration. It has been shown that Moloney Murine Leukemia Virus 
(MoMLV) exploits barrier-to-autointegration factor (BAF) to protect itself from 
autointegration (Lee and Craigie 1994; Lee and Craigie 1998). BAF is a 10-kDa 
conserved protein encoded by mammalian genomes. It binds DNA non-specifically 
and bridges double-stranded DNA, thereby assembling higher-order nucleoprotein 
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complexes and thus compacting DNA. Within retroviral preintegration complexes, 
viral DNA that is compacted by BAF is inaccessible as a target for integration (Bradley 
et al. 2005; Zheng et al. 2000).  As the assay bears similarities to the Mu in vitro 
transposition reaction, we wanted to test whether BAF could also decrease 
autointegration mediated by MuA. Recent in vivo studies have shown an effect of BAF 
also on the DNA transposition reactions of Sleeping Beauty (SB) and piggyBac (PB) 
transposons (Wang et al. 2014). The autointegration frequency was increased when the 
BAF gene was knocked down and decreased when the gene was overexpressed, 
suggesting that BAF is a general autointegration-inhibiting factor in eukaryotic cells 
(Wang et al. 2014). As BAF compacts DNA and binds double-stranded DNA non-
specifically (Bradley et al. 2005), it was feasible to think that BAF might make any 
transposon a less accessible target for autointegration. Results are shown below, but 
they are not included in the original publications. 
In these experiments the donor/target ratio was 10:1. Transpososomes were 
preassembled without divalent cations using 1 pmol Ori(pUC)-Cat-Mu transposon 
DNA. Different amounts of BAF were then added to enable DNA compaction by BAF. 
Strand transfer was initiated by the addition of pALH31 target DNA (0.1 pmol) and 
MgCl2, and following a brief incubation period, reaction products were electroporated 
into E. coli cells for selection on plates that contained the appropriate antibiotic(s). 
Overall, the decrease with BAF in the intra-/intermolecular product ratio was not 
statistically significant, although at 5 pmol BAF a low level of reduction was 
discernible. With higher amounts of BAF (25 and 50 pmol), an increase in the product 
ratio was actually observed (Figure 6). Thus, BAF is not an effective barrier to 
autointegration in a MuA-mediated in vitro transposition reaction.    
We believe that the data reflect fundamental differences between retrovirus integration 
by preintegration complexes and in vitro transposition by Mu transpososomes. 
Retroviral preintegration complexes include the virus DNA, a number of virus-encoded 
proteins, and certain host proteins that include BAF; instead, the Mu transpososomes 
used in the current study contain the transposon DNA and only one protein species, the 
MuA transposase. It may be that the recruitment to preintegration complexes and 
effective function of BAF require specific protein-protein interactions. For example, it 
has been suggested that in HIV-1 preintegration complexes, BAF is recruited via the 
viral protein gag (Mansharamani et al. 2003). Similarly, in SB transposition, BAF is 
enriched in a complex that contains SB transposase and its interactor HMGXB4 (Wang 
et al. 2014). Thus, the non-functionality of BAF for the inhibition of autointegration in 
our Mu in vitro transposition reactions might be due to the lack of such protein-protein 
interactions. It could also be that, although BAF can compact the Mu transposon DNA, 
the remaining free DNA sites still allow the transposon to insert into itself. However, in 
this study, BAF not only failed to inhibit autointegration, it actually increased the 
amount of intramolecular transposition relative to intermolecular transposition. This 
could have resulted from a MuB-like action on targeting. It has been suggested that the 
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bending or deformation of DNA at the ends of MuB filaments could create a favored 
target for Mu insertion (Mizuno et al. 2013). In summary, we conclude that BAF 
cannot act as an effective barrier of autointegration factor in a MuA-mediated in vitro 
transposition reaction. 
 
Figure 6. The effect of BAF for the ratio of intra-/intermolecular transposition reaction 
products. In vitro transposition reactions were conducted with 10:1 molar ratio of transposon 
Ori(pUC)-Cat-Mu to target pALH31 and different amounts of BAF. Reaction products were 
electroporated into DH10B E. coli strain and bacteria were selected with either chloramphenicol 
(Cm) or with double selection of chloramphenicol and kanamycin (Cm+Km). The ratio of 
intra/intermolecular transposition products is calculated as (CmR-CmRKmR)/CmRKmR. Results 
are shown as a mean of three replicates. The error bars indicate SD/2 above and below the 
average value of each data point. 
4.2.6.3 Simultaneous use of two transposons reduces intramolecular transposition 
(III) 
Previous experiments used transposons that contained both features that are essential 
for replication in E. coli under antibiotic selection: an origin of replication and a 
selectable marker. In theory, the background colonies resulting from a transposon 
inserting into itself could be eliminated by using two transposons, one providing the 
origin of replication and other the selectable marker. To test this, we incubated the 
ori(pUC)-Mu (contains pUC-ori) and Cat-Mu (contains the chloramphenicol-resistance 
marker) transposons simultaneously in one in vitro transposition reaction with variable 
amounts of the pALH31 target plasmid (Figure 5 in III). Our results demonstrated that 
the use of two transposons significantly reduced the frequency of, but did not eliminate 
intramolecular transposition. As intramolecular transposition products of neither of the 
two transposons can survive as stable plasmids inside the E. coli cells, we suggest that 
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the background colonies most probably contain transposon products in which one of 
the transposons has inserted into the other. 
We have shown that the frequency of intramolecular transposition can be reduced by 
increasing the relative amount of target DNA, by adding MuB into the transposition 
reaction, or by using two transposons. All these approaches enhanced the cloning 
efficiency. Adjusting the target/donor ratio was the simplest means to affect the 
intra/inter ratio, but it required that the target DNA was available in sufficient amounts. 
If only a limited amount of target DNA was available, use of two transposons was the 
most efficient means to enhance the cloning efficiency. Use of these different means to 
reduce the frequency of intramolecular transposition is beneficial in cloning, as they 
reduce the amount of screening that is needed to discover the properly targeted circles 
of interest.  
 Generation of hyperactive MuA transposase variants (IV) 
New applications for transposons in advanced molecular biology have led to the 
acceleration of efforts to develop hyperactive transposase variants. To improve the 
transposition system of Mu and facilitate the development of new applications, 
particularly in genomics but also in gene therapy and transgenesis, we mutagenized the 
MuA transposase protein and screened for hyperactive variants using an in vivo assay. 
Highly hyperactive versions of MuA were selected for further examination, and 
substitutions were studied both individually and in different combinations. Mapping 
the activity-enhancing substitutions on the Mu transpososome structure enabled us to 
identify the specific locations involved in both catalysis and associations between MuA 
subunits, as well as those between MuA and Mu DNA. Our results provide insights 
into the nature of hyperactivity in the context of the entire Mu transpososome, and they 
may help in generating hyperactive variants of other transposases.  
 Random MuA mutant libraries 
To generate a variety of substitutions in MuA, we used several different error-prone 
PCR protocols. A total of five MuA mutant libraries were generated, which included a 
total of ~3 × 105 independently generated plasmid clones (Supplementary Table 4 in 
IV). For papillation assays, these plasmids were introduced into DH5α cells, and 
altogether 64,000 colonies from different mutant libraries were screened for enhanced 
papillation. Approximately 1-3% of the clones per mutant library clearly exhibited an 
enhanced papillation frequency. These results showed that the mutagenesis protocols 
that we used were capable of producing a large number of desired hyperactive MuA 
variants.  
The amino-acid changes produced by any error-prone PCR mutagenesis method are 
most likely to be those that require only one nucleotide substitution, and therefore these 
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protocols do not generate all possible amino-acid changes. It has been shown that 
single-nucleotide mutations generate, on average, 5.7 different amino-acid 
substitutions for any given amino-acid residue (Miyazaki and Arnold 1999), which 
results in 39.5% coverage of the protein-level diversity (Wong et al. 2007). Although 
we were able to probe all of the important interfaces in the transpososome structure for 
amino-acid changes, it is possible that the most beneficial substitutions could not be 
identified for each amino-acid residue. An interesting topic for future studies would be 
to use, for example, the trinucleotide exchange method (TriNEx) to randomly replace 
amino-acid residues with all possible counterparts (Baldwin et al. 2008).  
 Random mutations in MuA can induce hyperactivity 
To verify that the observed high-papillation-activity phenotypes were caused by 
mutations in the MuA gene, we selected a large set of clones for further examination. 
Plasmids from 222 clones were re-assayed for papillation and the MuA gene was re-
cloned from 89 plasmids. Both of these re-examinations produced phenotypes identical 
to their respective original counterparts, showing that mutations in the MuA gene were 
indeed responsible for the observed phenotypes.    
To reveal changes at the amino-acid level, the MuA sequence was determined from the 
89 re-cloned plasmids. Of these, 71 were unique, and most contained several changes 
(Supplementary Table 5 in IV). To enable an accurate comparison between the 
transpositional activities of even the most active mutants, the plasmids were subjected 
to papillation analysis under stringent growth conditions (140 h incubation at 25˚C). 
These conditions revealed a broad spectrum of hyperactivity among the variants, and a 
correlation with specific amino-acid changes was apparent (Figure 3 and 
Supplementary Table 5 in IV). Although many changes were identified only once, 
certain mutations were identified frequently and a number of clear hot spots could be 
found. Presumably many of the changes that were identified only once were irrelevant 
for the hyperactive phenotype. This demonstrated that the papillation analysis was 
effective in screening for mutations that cause hyperactive phenotypes.  
 Single-substitution MuA variants 
To study substitutions individually, we generated 47 single-substitution MuA variants. 
The substitutions were selected so that they represented all MuA subdomains. Other 
criteria were their presence in several independent clones or their presence in an 
individual clone of high activity (Figure 3 and Supplementary Table 5 in IV). To 
quantify the transpositional activity of the constructed plasmids, we subjected them to 
papillation analysis (115 h incubation at 30˚C) (Figure 4 in IV). At least a two-fold 
increase in protein activity was observed with 34 substitutions at 26 specific amino-
acid residues and more than a five-fold activity enhancement was detected with 27 
substitutions. The highest increase in activity was 50-fold over the wild-type level. 
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These results indicated that a variety of substitutions in different subdomains resulted 
in the hyperactivity of MuA.  
 Activity-enhancing single substitutions in different domains of MuA 
To allow structure-function analysis, activity-enhancing substitutions were mapped on 
the recently resolved Mu transpososome structure. Each of the MuA subdomains 
contained activity-enhancing substitutions, although domains Iα and IIIβ each 
contained only one substitution, and those enhanced activity only slightly. The Iα and 
IIIβ domains are associated with the binding of the enhancer sequence and MuB 
protein, respectively, and both of these features are missing in our transposition assay. 
It has been previously shown that domain Iα is inhibitory in the absence of the 
enhancer (Mizuuchi and Mizuuchi 1989; Pajunen et al. 2010; Yang et al. 1995), and N-
terminal deletion variants demonstrate significantly improved activity (Pajunen et al. 
2010). As the Iα and IIIβ domains are not involved in the transpososome crystal 
structure, a detailed functional explanation of the effect of these residues is not 
currently possible. 
The substitutions that most enhanced activity were located in the central subdomains, 
from Iβ to IIIα. When mapped to the Mu transpososome structure, many of these 
substitutions were found to be at the interface between the Iβ domain (residues 97 and 
160) of the R1-bound subunit and the IIα subdomain (residues 478, 482, 483, and 487) 
of the R2-bound subunit, which are located in the same DNA segment (Figure 6 in IV). 
These substitutions may possibly enhance activity by improving protein-protein 
interactions. In addition, important activity-enhancing substitutions were located at the 
interface between the IIβ and IIIα subdomains of the R2-bound subunit and the Mu-
end recognition and binding domain Iγ (residues 232 and 233) of the R1-bound subunit 
(Figure 6C in IV). The most active single-amino-acid substitution variants were E233K 
and E233V, and the hyperactivity caused by these substitutions is possibly a result of 
electrostatic changes which might affect protein-protein interactions.  
The vast majority of the hyperactivity-inducing mutations were found near the catalytic 
subdomain IIα (residues 302, 302, 335, 340, 345, 345, 374, and 374) of the R1-bound 
subunits (Figure 6D in IV). Several of these substitutions change the packing and 
flexibility properties of the residue, and they most probably affect the packing of the 
catalytic core. Other hyperactivity-inducing substitutions found in subdomain IIα of the 
R1-bound subunits (residues 254, 258, 447, 447, 464, and 466) may affect the 
conformational changes required for the assembly of a catalytically competent 
transpososome.   
Some of the hyperactivity-inducing substitutions probably improve interactions with 
DNA on both the R1 and R2 subunits (Figure 6E and 6F in IV). For example, 
substitution with a less-negative amino acid at residue E179, which is close to Mu-end 
DNA in both R1 and R2 subunits, could improve DNA binding. Likewise, a 
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substitution of the Q594 residue, which is close to target DNA on the R1-bound 
subunit and flanking host DNA on the R2-bound subunit, may improve DNA 
interactions. 
In summary, the results demonstrated that the activity-inducing substitutions have an 
effect on different phases of the transposition pathway, including tetramer assembly, 
catalysis, DNA binding, and folding properties of the MuA protein.  
 Synergistic effects of substitutions 
Although activity enhancement was detected with the single-substitution variants, the 
most-active MuA variants contained multiple substitutions. This suggested that the 
substitutions had synergistic effects. The most-active MuA variant (clone EP3I4) 
contained five amino-acid substitutions (W160R, A234V, W345R, M374V, and 
T543A) (Figure 7 and Supplementary Table 5 in IV).  Three of these substitutions 
(W160R, W345R, and M374V) were found to increase activity over the wild-type level 
when studied individually (Figure 7 and Table 2 in IV). In order to study their 
synergistic effects, these three substitutions were grouped in double- and triple-
substitution combinations. Of these combinations, the triple-substitution mutant 
(W160R, W345R, M374V) generated the highest activity (~264 papillae per colony) 
and produced the same degree of activity as the original variant, EP3I4 (~295 papillae 
per colony) (Table 2 in IV). To examine the effect of combining mutations from three 
different subdomains, we changed the M374V mutation to E233K. This variant 
(W160R, E233K, W345R) was even more active (~519 papillae per colony) than the 
original EP3I4 (~295 papillae per colony) (Table 2 in IV). Thus, these results showed 
that the substitutions had synergistic effects and emphasized the independent roles of 
MuA subdomains in generating hyperactive variants. 
 MuA variants for application purposes 
The papillation assays we conducted quantified the transpositional activity of the MuA 
variants in vivo. To assess the transpositional activity of MuA variants in two assays, in 
vitro assay and in in vivo assay with pre-assembled transpososomes, we purified wild 
type MuA, 30 single-substitution MuA variants and a triple mutant (W160R, E233K, 
W345R)  (Figures 8 and 9, Supplementary Figures 2 and 3 in IV). In the in vitro assay, 
plasmid DNA was used as a target for transposon integrations, and in in vivo assay, the 
target was chromosomal DNA. Differently from the in vitro assay, in the in vivo assay, 
pre-assembled transpososomes encounter Mg2+ ions and thus become active only after 
electroporation into the E. coli cells.   
For the in vitro transposition reactions with the MuA variants, we used a pre-cleaved 
mini-Mu transposon as donor DNA and the pUC19 plasmid as a target (Figure 8A in 
IV). Reaction products were transformed into competent E. coli cells and plated on 
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appropriate antibiotic selection plates in order to score integration events into target 
plasmids (Figure 8B in IV). In addition, reaction products were analyzed qualitatively 
by agarose gel electrophoresis (Supplementary Figure 2 in IV). In the in vivo assay 
with pre-assembled transpososomes, we incubated the pre-cleaved mini-Mu transposon 
with MuA variants and electroporated the pre-assembled complexes into E. coli cells 
(Figure 9 in IV). Transpososome formation was assayed by native gel electrophoresis 
(Supplementary figure 3 in IV). In both assays, the vast majority of MuA variants 
demonstrated levels of activity that were at least equivalent to the wild type, and most 
were higher. However, the activity range detected in vitro was narrower than that 
detected with the papillation assay, and one variant (D320V) was totally inactive in 
vitro. In addition, the activities of the variants differed somewhat more from their in 
vivo papillation activities when quantified with the assay with pre-assembled 
transposition complexes, than with the in vitro transposition reactions.       
Both the in vitro transposition reaction and in vivo papillation assay simulate the entire 
transposition pathway from assembly to catalysis; the main difference between the two 
is that the in vitro reaction utilizes pre-cut substrates, and therefore does not involve 
the donor cleavage step which occurs in the papillation assay. The differences between 
the results of the in vitro and in vivo (papillation) assays may reflect the influence of 
host factors. In the assay with the pre-assembled transposition complexes, the 
transposition pathway differs more from the in vivo papillation assay, as the complex 
assembly process is separate from integration into the target. Similar differences in 
activities between in vivo and in vitro assays have been detected also in other 
transposition systems with hyperactive transposases (Lampe et al. 1999).  
 Further studies on synergism 
As the mutant proteins with three substitutions were highly active, we wanted to study 
whether the protein activity could be increased even further by adding more 
substitutions to the protein (Table 1 in IV). Initially, transpositional activities of the 
mutant combinations were assessed using the papillation assay, and all the mutant 
combination variants were extremely efficient (up to 6-fold activity enhancement over 
the highly active control triple-substitution mutant) (Figure 10 in IV). Next, the 
transpositional activity of purified mutant combination variants was assessed in two 
assays, in vitro assay and in in vivo assay with pre-assembled transpososomes (Figure 
11 in IV), but the increase in transpositional activity observed with the purified mutant 
combination variants was not higher than that found with the purified single-
substitution variants. However, even a small improvement in efficiency compared to 
the wild type level makes a significant contribution to transgenesis and gene therapy 
approaches and to the development of novel applications based on the Mu system. In 
addition, studies which combine analysis of structure and function greatly benefit 
future efforts to systematically design new mutants with features appropriate to a given 
task.  
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5 CONCLUSIONS AND FUTURE PERSPECTIVES 
This study established novel Mu transposition-based molecular genetics tools and 
generated MuA transposase variants with altered transposition frequency.  
The main findings and conclusions are as follows: 
1. A general-purpose test to measure the specific activity of transposition 
complexes was established using phage Mu transposition as a test platform. This 
assay utilizes a common suicide target, is applicable to all types of transposons 
that have a functional in vitro reaction, and allows the direct comparison of 
transpositional activities within or between particular experimental systems. The 
assay is particularly useful with transposons that do not contain selectable 
marker genes or contain markers that are functional only in eukaryotic cells.  
2. A Mu transposition-based cloning strategy for replication-deficient circular 
DNA was developed. This method utilizes a transposon that contains an origin 
of replication and an antibiotic-selection marker gene. The method can be used 
for cloning or “rescuing” circular DNA that does not contain a selectable marker 
(including cryptic plasmids, circular recombination intermediates, and mtDNA). 
In essence, these circles are transfigured into plasmids or bacterial artificial 
chromosomes which then are able to replicate in E. coli. The method enables the 
cloning of circular DNA from very low target amounts, even in the presence of 
contaminating linear DNA fragments. The donor/target ratio was found to be the 
major factor affecting the frequency of intramolecular transposition. The use of 
the MuB protein enabled us to reduce intramolecular transposition.  
3. A platform with ten mini-Mu transposons for the Mu transposition-based 
cloning strategy for replication-deficient circular DNA was established. An 
assortment of replication origins enables several different approaches for the 
study of DNA-circles of interest. The simultaneous use of two transposons (one 
containing an origin of replication and other containing a selection marker) in 
one reaction substantially reduced the amount of intramolecular transposition.  
4. Hyperactive MuA variants were generated by mutagenizing the catalytic MuA 
transposase protein and screened using an in vivo papillation assay. The 
papillation assay enabled us to identify various individual substitutions that 
increased transposition activity with respect to that of the wild-type MuA 
protein. Structure-function studies indicated that the activity-enhancing 
substitutions have an effect on different phases of the transposition pathway, 
including tetramer assembly, catalysis, DNA binding, and folding of the MuA 
protein. 
50 Conclusions and Future Perspectives  
The four studies I have presented extend the variety of Mu-based tools available and 
enable more efficient use of the Mu in vitro transposition reaction for different 
applications. Furthermore, the method developed for the measurement of the specific 
activity of transposition complexes should also be directly applicable to other 
transposition-based systems with a functional in vitro reaction and therefore could 
provide a common transposon-based tool.   
Transposon-based tools are under active development, with constant efforts being 
made to enhance transpositional activity. The hyperactive MuA variants generated in 
this study will improve the utility of MuA-based tools and can promote the 
development of new applications also in the disciplines of gene therapy and gene 
delivery in mammalian cells.  
Although transposon-based technologies are currently more extensively used in 
bacterial and invertebrate models, current progress in transposon research indicates 
that, in the future, they will serve as indispensable tools in the biotechnology toolkit 
also for vertebrate models, in which the full potential of transposons as gene-delivery 
vehicles can be exploited.   
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